
{
    "FullStudiesResponse":{
      "APIVrs":"1.01.05",
      "DataVrs":"2023:08:16 23:57:56.293",
      "Expression":"NCT02651987",
      "NStudiesAvail":462815,
      "NStudiesFound":1,
      "MinRank":1,
      "MaxRank":1,
      "NStudiesReturned":1,
      "FullStudies":[
        {
          "Rank":1,
          "Study":{
            "ProtocolSection":{
              "IdentificationModule":{
                "NCTId":"NCT02651987",
                "OrgStudyIdInfo":{
                  "OrgStudyId":"8-79-52030-326"
                },
                "SecondaryIdInfoList":{
                  "SecondaryIdInfo":[
                    {
                      "SecondaryId":"2014-005607-24",
                      "SecondaryIdType":"EudraCT Number"
                    }
                  ]
                },
                "Organization":{
                  "OrgFullName":"Ipsen",
                  "OrgClass":"INDUSTRY"
                },
                "BriefTitle":"Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg",
                "OfficialTitle":"Efficacy and Safety of Lanreotide Autogel® 120 mg Administered Every 14 Days in Well Differentiated, Metastatic or Locally Advanced, Unresectable Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg Administered Every 28 Days",
                "Acronym":"CLARINET FORTE"
              },
              "StatusModule":{
                "StatusVerifiedDate":"September 2022",
                "OverallStatus":"Completed",
                "ExpandedAccessInfo":{
                  "HasExpandedAccess":"No"
                },
                "StartDateStruct":{
                  "StartDate":"December 15, 2015",
                  "StartDateType":"Actual"
                },
                "PrimaryCompletionDateStruct":{
                  "PrimaryCompletionDate":"October 16, 2019",
                  "PrimaryCompletionDateType":"Actual"
                },
                "CompletionDateStruct":{
                  "CompletionDate":"October 24, 2019",
                  "CompletionDateType":"Actual"
                },
                "StudyFirstSubmitDate":"December 11, 2015",
                "StudyFirstSubmitQCDate":"January 7, 2016",
                "StudyFirstPostDateStruct":{
                  "StudyFirstPostDate":"January 11, 2016",
                  "StudyFirstPostDateType":"Estimate"
                },
                "ResultsFirstSubmitDate":"October 16, 2020",
                "ResultsFirstSubmitQCDate":"December 4, 2020",
                "ResultsFirstPostDateStruct":{
                  "ResultsFirstPostDate":"December 30, 2020",
                  "ResultsFirstPostDateType":"Actual"
                },
                "LastUpdateSubmitDate":"September 21, 2022",
                "LastUpdatePostDateStruct":{
                  "LastUpdatePostDate":"October 3, 2022",
                  "LastUpdatePostDateType":"Actual"
                }
              },
              "SponsorCollaboratorsModule":{
                "ResponsibleParty":{
                  "ResponsiblePartyType":"Sponsor"
                },
                "LeadSponsor":{
                  "LeadSponsorName":"Ipsen",
                  "LeadSponsorClass":"INDUSTRY"
                }
              },
              "OversightModule":{
                "OversightHasDMC":"Yes"
              },
              "DescriptionModule":{
                "BriefSummary":"This study aims to explore the efficacy and safety of lanreotide Autogel® 120 mg administered every 14 days in subjects with grade 1 or 2, metastatic or locally advanced, unresectable pancreatic or intestinal neuroendocrine tumours (NETs) once they have progressed on the standard dose of lanreotide Autogel® 120 mg every 28 days."
              },
              "ConditionsModule":{
                "ConditionList":{
                  "Condition":[
                    "Pancreatic Tumours",
                    "Midgut Neuroendocrine Tumours"
                  ]
                }
              },
              "DesignModule":{
                "StudyType":"Interventional",
                "PhaseList":{
                  "Phase":[
                    "Phase 2"
                  ]
                },
                "DesignInfo":{
                  "DesignAllocation":"N/A",
                  "DesignInterventionModel":"Single Group Assignment",
                  "DesignPrimaryPurpose":"Treatment",
                  "DesignMaskingInfo":{
                    "DesignMasking":"None (Open Label)"
                  }
                },
                "EnrollmentInfo":{
                  "EnrollmentCount":"99",
                  "EnrollmentType":"Actual"
                }
              },
              "ArmsInterventionsModule":{
                "ArmGroupList":{
                  "ArmGroup":[
                    {
                      "ArmGroupLabel":"Lanreotide Autogel®",
                      "ArmGroupType":"Experimental",
                      "ArmGroupDescription":"One subcutaneous (SC) injection of lanreotide Autogel® 120mg every 14 days until disease progression or death or unacceptable toxicity or tolerability.",
                      "ArmGroupInterventionList":{
                        "ArmGroupInterventionName":[
                          "Drug: Lanreotide autogel 120 mg"
                        ]
                      }
                    }
                  ]
                },
                "InterventionList":{
                  "Intervention":[
                    {
                      "InterventionType":"Drug",
                      "InterventionName":"Lanreotide autogel 120 mg",
                      "InterventionArmGroupLabelList":{
                        "InterventionArmGroupLabel":[
                          "Lanreotide Autogel®"
                        ]
                      }
                    }
                  ]
                }
              },
              "OutcomesModule":{
                "PrimaryOutcomeList":{
                  "PrimaryOutcome":[
                    {
                      "PrimaryOutcomeMeasure":"Median Progression Free Survival (PFS)",
                      "PrimaryOutcomeDescription":"PFS was defined as the time from first injection of lanreotide Autogel® 120 mg every 14 days to progression or death. Disease progression was assessed by tumour response evaluation according to RECIST v1.0, every 12 weeks, measured by independent central review using the same imaging technique (computed tomography [CT] scan or magnetic resonance imaging [MRI]) for each subject throughout the study. The median PFS time was estimated using the Kaplan Meier method for each cohort.",
                      "PrimaryOutcomeTimeFrame":"From Day 1 up to Week 60 for the panNET cohort and Week 103 for the midgut NET cohort"
                    }
                  ]
                },
                "SecondaryOutcomeList":{
                  "SecondaryOutcome":[
                    {
                      "SecondaryOutcomeMeasure":"Median Time to Progression",
                      "SecondaryOutcomeDescription":"Time to Progression was defined as time from first injection of lanreotide Autogel® 120 mg every 14 days to progression. Disease progression was assessed by tumour response evaluation according to RECIST v1.0, every 12 weeks, measured by independent central review using the same imaging technique (CT scan or MRI) for each subject throughout the study. Median time to progression was estimated using the Kaplan Meier method for each cohort.",
                      "SecondaryOutcomeTimeFrame":"From Day 1 up to Week 60 for the panNET cohort and Week 103 for the midgut NET cohort"
                    },{
                      "SecondaryOutcomeMeasure":"Percentage of Subjects Alive and Progression Free",
                      "SecondaryOutcomeDescription":"The percentage of subjects alive and progression-free was assessed throughout the study up to Week 60 for the panNET cohort and Week 96 for the midgut cohort. Disease progression was assessed by tumour response evaluation according to RECIST v1.0, every 12 weeks measured by independent central review using the same imaging technique (CT scan or MRI) for each subject throughout the study. The percentage of subjects alive and progression free was estimated using the Kaplan Meier method for each cohort.",
                      "SecondaryOutcomeTimeFrame":"Weeks 12, 24, 36, 48, 60 (for both cohorts) and Weeks 72, 84 and 96 (for midgut NET cohort)"
                    },{
                      "SecondaryOutcomeMeasure":"Overall Survival",
                      "SecondaryOutcomeDescription":"Overall survival was defined as the time in months from the first injection of lanreotide Autogel® 120 mg every 14 days to death due to any cause. Median overall survival was estimated using the Kaplan Meier method for each cohort.",
                      "SecondaryOutcomeTimeFrame":"From Day 1 up to Week 60 for the panNET cohort and Week 103 for the midgut NET cohort"
                    },{
                      "SecondaryOutcomeMeasure":"Objective Response Rate (ORR)",
                      "SecondaryOutcomeDescription":"The ORR was defined as the percentage of subjects who achieve either complete response (CR) or partial response (PR) according to RECIST v1.0 criteria. ORR was evaluated every 12 weeks and results are presented for each cohort.",
                      "SecondaryOutcomeTimeFrame":"Weeks 12, 24, 36, 48, 60 (for both cohorts) and Weeks 72, 84, and 96 (for midgut cohort)"
                    },{
                      "SecondaryOutcomeMeasure":"Disease Control Rate (DCR)",
                      "SecondaryOutcomeDescription":"The DCR was defined as the percentage of subjects who achieved CR plus PR plus Stable Disease (SD), evaluated according to RECIST v1.0 criteria. The DCR at Weeks 24 and 48 is presented for each cohort.",
                      "SecondaryOutcomeTimeFrame":"Weeks 24 and 48"
                    },{
                      "SecondaryOutcomeMeasure":"Best Overall Response Rate",
                      "SecondaryOutcomeDescription":"Best overall response was defined as the best response recorded from the initiation of treatment until disease progression, according to RECIST v1.0 evaluation. The percentage of subjects in each response category and those who were non-evaluable (i.e. with no tumour assessment after the start of study treatment) throughout the study are presented for each cohort.",
                      "SecondaryOutcomeTimeFrame":"From Day 1 up to Week 60 for the panNET cohort and Week 103 for the midgut NET cohort"
                    },{
                      "SecondaryOutcomeMeasure":"Median Duration of Stable Disease",
                      "SecondaryOutcomeDescription":"Median duration of SD was the time from first injection of lanreotide Autogel® 120 mg every 14 days until the first occurrence of PD by central assessment. Disease progression was assessed by tumour response evaluation according to RECIST v1.0, every 12 weeks, measured using the same imaging technique (CT scan or MRI) for each subject throughout the study. Median duration of stable disease was estimated using the Kaplan Meier method for each cohort.",
                      "SecondaryOutcomeTimeFrame":"From Day 1 up to Week 60 for the panNET cohort and Week 103 for the midgut NET cohort"
                    },{
                      "SecondaryOutcomeMeasure":"Factors Associated With PFS",
                      "SecondaryOutcomeDescription":"A univariate cox proportional hazards model was used to assess whether the following factors were associated with PFS:\n\nHepatic tumour load: >25% versus reference ≤25%\nTumour Grade: Grade 2 versus reference Grade 1,\nPrevious surgery of the primary tumour: No versus reference Yes,\nProliferation index Ki67: ≥10% versus reference <10%\nDuration of treatment with lanreotide Autogel® 120 mg every 28 days by category: ≥median value versus reference <median value,\nAge by category: ≥65 years versus reference <65 years,\nTime from diagnosis to study entry by category: ≥3 years versus reference <3 years,\nTime interval between the two CT scans (pre-screening/screening): ≥12 months versus reference <12 months and\nSymptoms (diarrhoea or flushing at baseline): No versus reference Yes.\n\nEach factor was assessed for its importance in the Cox model for PFS in a univariate fashion.",
                      "SecondaryOutcomeTimeFrame":"Screening/Baseline (Day 1)"
                    },{
                      "SecondaryOutcomeMeasure":"Mean Change From Baseline in Number of Stools and Flushing Episodes",
                      "SecondaryOutcomeDescription":"Symptom control was measured by the total number of stools (diarrhoea) and flushing episodes during the 7 days prior to the visit, reported orally by the subject to the investigator. The mean change from baseline in number of stools and flushing episodes reported at each visit is presented for each cohort.",
                      "SecondaryOutcomeTimeFrame":"Baseline (Day 1), Weeks 8,12, 48 and end of study (approximately 64 weeks for panNET cohort and 108 weeks for midgut NET cohort)"
                    },{
                      "SecondaryOutcomeMeasure":"Mean Change From Baseline in QoL Measured Using EORTC, QLQ-C30 v3.0 (Global Health Status Sub-score)",
                      "SecondaryOutcomeDescription":"Subjects were instructed to complete the 30 questions in the EORTC-QLQ-C30 v3.0 questionnaire at baseline and every 12 weeks throughout the study.\n\nThe global health status sub-score was assessed using the last 2 questions which represented subject's assessment of overall health & QoL. Each question was coded on a 7-point scale (1=very poor to 7=excellent). The sub-score was transformed to range from 0-100, with a high score for global health status representing a high QoL. The mean change from baseline in the transformed global health status are presented for the end of study/early withdrawal visit, with a positive change indicating an improvement in QoL.",
                      "SecondaryOutcomeTimeFrame":"Baseline (Day 1) and end of study (approximately 64 weeks for panNET cohort and 108 weeks for midgut NET (and overall) cohort)"
                    },{
                      "SecondaryOutcomeMeasure":"Mean Change From Baseline in EQ-5D-5L v1.0 Questionnaire (Descriptive System)",
                      "SecondaryOutcomeDescription":"Subjects were instructed to complete the EQ-5D-5L descriptive system at baseline and every 12 weeks throughout the study.\n\nThe EQ-5D-5L descriptive system comprised the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension had 5 levels: no problems, slight problems, moderate problems, severe problems, extreme problems. The EQ-5D-5L health states, defined by the EQ-5D-5L descriptive system, was converted into a single index value with scores ranging from 0 (no problems) to 1 (extreme problems). The mean change from baseline at the end of study/early withdrawal visit is presented with a positive change from baseline in the index values indicating a worsening of symptoms.",
                      "SecondaryOutcomeTimeFrame":"Baseline (Day 1) and end of study (approximately 64 weeks for panNET cohort and 108 weeks for midgut NET (and overall) cohort)"
                    },{
                      "SecondaryOutcomeMeasure":"Mean Change From Baseline in EQ-5D-5L v1.0 Questionnaire (VAS)",
                      "SecondaryOutcomeDescription":"Subjects were instructed to complete the EQ-5D-5L VAS at baseline and every 12 weeks throughout the study. The EQ-5D-5L VAS recorded the subject's self-rated health on a vertical VAS which is numbered from 0 (worst health state) to 100 (best health state). The mean change from baseline at the end of study/early withdrawal visit is presented with a positive change in the VAS indicating an improvement in symptoms.",
                      "SecondaryOutcomeTimeFrame":"Baseline (Day 1) and end of study (approximately 64 weeks for panNET cohort and 108 weeks for midgut NET (and overall) cohort)"
                    },{
                      "SecondaryOutcomeMeasure":"Mean Change From Baseline in QoL Questionnaire Gastrointestinal Neuroendocrine Tumour 21 (QLQ-GI.NET21; 2006)",
                      "SecondaryOutcomeDescription":"Subjects were asked to complete the EORTC QLQ-GI.NET21 module which comprised 21 questions that used a 4-point scale (1 = Not at all, 2 = A little, 3 = Quite a bit, 4 = Very much) to evaluate 3 defined multi-item symptom scales (endocrine, gastrointestinal and treatment related side effects), 2 single item symptoms (bone/muscle pain and concern about weight loss), 2 psychosocial scales (social function and disease-related worries) and 2 other single items (sexuality and communication). Answers were converted into grading scale, with values between 0 and 100. Each individual sub-score was transformed to range from 0 to 100. The mean change from baseline at the end of study/early withdrawal visit is presented with a higher score representing more or worse problems.",
                      "SecondaryOutcomeTimeFrame":"Baseline (Day 1) and end of study (approximately 64 weeks for panNET cohort and 108 weeks for midgut NET (and overall) cohort)"
                    },{
                      "SecondaryOutcomeMeasure":"Mean Change From Baseline in Nonspecific Tumour Biomarkers",
                      "SecondaryOutcomeDescription":"Nonspecific tumour peptide biomarkers (chromogranin A [CgA], neuron specific enolase [NSE] and plasma/urinary 5-hydroxyindoleacetic acid [5-HIAA]) were evaluated in both pancreas and midgut subjects at baseline and Week 12 and every 12 weeks thereafter. At all scheduled visits, except baseline, plasma/urinary 5-HIAA was only performed in subjects with symptoms of carcinoid syndrome (diarrhoea and/or flushing) or if urinary 5-HIAA was elevated (above upper limit of normal [ULN]) at baseline. Mean change from baseline values were normalised by the ULN (xULN) and are presented for each cohort.",
                      "SecondaryOutcomeTimeFrame":"Baseline (Day 1) and end of study (approximately 64 weeks for panNET cohort and 108 weeks for midgut NET cohort)"
                    },{
                      "SecondaryOutcomeMeasure":"Mean Change From Baseline in PanNet Specific Tumour Biomarkers: Pancreatic Polypeptide, Gastrin",
                      "SecondaryOutcomeDescription":"PanNET specific tumour peptide biomarkers were evaluated in pancreas subjects at baseline. Only the tumour biomarkers that were above normal range at baseline were evaluated every 12 weeks thereafter and at the end of study visit. The mean change from baseline values in picomole/liter (pmol/L) are presented for the end of study visit.",
                      "SecondaryOutcomeTimeFrame":"Baseline (Day 1) and end of study (approximately 64 weeks)"
                    },{
                      "SecondaryOutcomeMeasure":"Mean Change From Baseline in PanNet Specific Tumour Biomarkers: Glucagon",
                      "SecondaryOutcomeDescription":"PanNET specific tumour peptide biomarkers were evaluated in pancreas subjects at baseline. Only the tumour biomarkers that were above normal range at baseline were evaluated every 12 weeks thereafter and at the end of study visit. The mean change from baseline values in nanograms (ng)/L are presented for the end of study visit.",
                      "SecondaryOutcomeTimeFrame":"Baseline (Day 1) and end of study (approximately 64 weeks)"
                    }
                  ]
                }
              },
              "EligibilityModule":{
                "EligibilityCriteria":"Inclusion Criteria:\n\nHistopathologically confirmed, grade 1 or 2, metastatic or locally advanced, unresectable pNET (pNET cohort) or midgut NET (midgut cohort) with or without hormone related syndromes, with a proliferation index (Ki67) ≤20%.\nPositive somatostatin receptors type 2\nProgression as assessed by an independent central reviewer according to RECIST v1.0 while receiving first line treatment with lanreotide Autogel® at a standard dose of 120 mg every 28 days for at least 24 weeks\n\nExclusion Criteria:\n\nGrade 3 or rapidly progressive (within 12 weeks) NET\nAny NET other than pancreatic and midgut\nPrevious treatment with any antitumour agent for NET other than lanreotide Autogel® 120 mg every 28 days. Exception made of prior treatment with Octreotide at standard dose stopped for other reason than disease progression.\nSymptomatic gallbladder lithiasis at screening echography or history of cholelithiasis with no cholecystectomy since then.",
                "HealthyVolunteers":"No",
                "Gender":"All",
                "MinimumAge":"18 Years",
                "StdAgeList":{
                  "StdAge":[
                    "Adult",
                    "Older Adult"
                  ]
                }
              },
              "ContactsLocationsModule":{
                "OverallOfficialList":{
                  "OverallOfficial":[
                    {
                      "OverallOfficialName":"Ipsen Medical Director",
                      "OverallOfficialAffiliation":"Ipsen",
                      "OverallOfficialRole":"Study Director"
                    }
                  ]
                },
                "LocationList":{
                  "Location":[
                    {
                      "LocationFacility":"Erasme Hospital",
                      "LocationCity":"Bruxelles",
                      "LocationZip":"1070",
                      "LocationCountry":"Belgium"
                    },{
                      "LocationFacility":"Cliniques Unversitaires Saint Luc",
                      "LocationCity":"Bruxelles",
                      "LocationZip":"1200",
                      "LocationCountry":"Belgium"
                    },{
                      "LocationFacility":"Antwerp University Hospital",
                      "LocationCity":"Edegem",
                      "LocationZip":"2650",
                      "LocationCountry":"Belgium"
                    },{
                      "LocationFacility":"UZ Leuven",
                      "LocationCity":"Leuven",
                      "LocationZip":"B-3000",
                      "LocationCountry":"Belgium"
                    },{
                      "LocationFacility":"Aarhus University Hospital",
                      "LocationCity":"Aarhus",
                      "LocationCountry":"Denmark"
                    },{
                      "LocationFacility":"Rigshospitalet",
                      "LocationCity":"København",
                      "LocationZip":"2100",
                      "LocationCountry":"Denmark"
                    },{
                      "LocationFacility":"Hôpital Beaujon",
                      "LocationCity":"Clichy",
                      "LocationZip":"92118",
                      "LocationCountry":"France"
                    },{
                      "LocationFacility":"Hôpital Edouard Herriot",
                      "LocationCity":"Lyon",
                      "LocationZip":"69437",
                      "LocationCountry":"France"
                    },{
                      "LocationFacility":"Institut Paoli Calmette",
                      "LocationCity":"Marseille",
                      "LocationZip":"13273",
                      "LocationCountry":"France"
                    },{
                      "LocationFacility":"Institut Gustave Roussy",
                      "LocationCity":"Villejuif",
                      "LocationZip":"94805",
                      "LocationCountry":"France"
                    },{
                      "LocationFacility":"Charité - CVK",
                      "LocationCity":"Berlin",
                      "LocationZip":"13353",
                      "LocationCountry":"Germany"
                    },{
                      "LocationFacility":"Universitätsklinikum Erlangen",
                      "LocationCity":"Erlangen",
                      "LocationZip":"91054",
                      "LocationCountry":"Germany"
                    },{
                      "LocationFacility":"Nationales Centrum für Tumorerkrankungen (NCT)",
                      "LocationCity":"Heidelberg",
                      "LocationZip":"69120",
                      "LocationCountry":"Germany"
                    },{
                      "LocationFacility":"St Vincent's University Hospital",
                      "LocationCity":"Dublin",
                      "LocationZip":"D4",
                      "LocationCountry":"Ireland"
                    },{
                      "LocationFacility":"IRCCS Azienda Ospedaliera Universitaria",
                      "LocationCity":"San Martino",
                      "LocationState":"Genova",
                      "LocationZip":"16132",
                      "LocationCountry":"Italy"
                    },{
                      "LocationFacility":"Azienda Ospedaliera - Universitaria Careggi",
                      "LocationCity":"Firenze",
                      "LocationZip":"50134",
                      "LocationCountry":"Italy"
                    },{
                      "LocationFacility":"Fondacione IRCCS Istituto Nazionale Dei Tumori",
                      "LocationCity":"Milano",
                      "LocationZip":"20133",
                      "LocationCountry":"Italy"
                    },{
                      "LocationFacility":"Università degli Studi \"Federico II\" di Napoli",
                      "LocationCity":"Napoli",
                      "LocationZip":"80131",
                      "LocationCountry":"Italy"
                    },{
                      "LocationFacility":"Azienda Ospedaliera sant'Andrea",
                      "LocationCity":"Roma",
                      "LocationZip":"00189",
                      "LocationCountry":"Italy"
                    },{
                      "LocationFacility":"AVL/NKI Medisch Oncologie",
                      "LocationCity":"Amsterdam",
                      "LocationZip":"1066",
                      "LocationCountry":"Netherlands"
                    },{
                      "LocationFacility":"Academic Medical Center",
                      "LocationCity":"Amsterdam",
                      "LocationZip":"1105",
                      "LocationCountry":"Netherlands"
                    },{
                      "LocationFacility":"Erasmus MC",
                      "LocationCity":"Rotterdam",
                      "LocationZip":"3015",
                      "LocationCountry":"Netherlands"
                    },{
                      "LocationFacility":"Samodzielny Publiczny Szpital Kliniczny nr 5",
                      "LocationCity":"Katowice",
                      "LocationZip":"40-952",
                      "LocationCountry":"Poland"
                    },{
                      "LocationFacility":"Katedra i Klinika Endokrynologii",
                      "LocationCity":"Poznan",
                      "LocationZip":"60-355",
                      "LocationCountry":"Poland"
                    },{
                      "LocationFacility":"Centrum Diagnostyczno-Lecznicze \"GAMMED\"",
                      "LocationCity":"Warsaw",
                      "LocationZip":"02-348",
                      "LocationCountry":"Poland"
                    },{
                      "LocationFacility":"Hospital Universitario Vall D'hebron",
                      "LocationCity":"Barcelona",
                      "LocationZip":"08034",
                      "LocationCountry":"Spain"
                    },{
                      "LocationFacility":"Hospital Universitario Ramón Y Cajal",
                      "LocationCity":"Madrid",
                      "LocationZip":"28034",
                      "LocationCountry":"Spain"
                    },{
                      "LocationFacility":"Hospital Universitario 12 De Octubre",
                      "LocationCity":"Madrid",
                      "LocationZip":"28041",
                      "LocationCountry":"Spain"
                    },{
                      "LocationFacility":"Hospital Universitario Central de Asturias",
                      "LocationCity":"Oviedo",
                      "LocationZip":"33011",
                      "LocationCountry":"Spain"
                    },{
                      "LocationFacility":"Queen Elizabeth Medical Center",
                      "LocationCity":"Birmingham",
                      "LocationZip":"B15 2TH",
                      "LocationCountry":"United Kingdom"
                    },{
                      "LocationFacility":"Royal Free Hospital",
                      "LocationCity":"London",
                      "LocationZip":"NW3 2QG",
                      "LocationCountry":"United Kingdom"
                    },{
                      "LocationFacility":"The Christie Hospital NHS Foundation Trust",
                      "LocationCity":"Manchester",
                      "LocationZip":"M20 4BX",
                      "LocationCountry":"United Kingdom"
                    }
                  ]
                }
              }
            },
            "ResultsSection":{
              "ParticipantFlowModule":{
                "FlowPreAssignmentDetails":"Subjects who had centrally reviewed, radiologically documented disease progression within 24 months prior to enrolment and whilst receiving treatment with lanreotide Autogel® 120 mg, administered every 28 days for at least 24 weeks, were recruited into one of two cohorts based on the primary location of NET (i.e. pancreatic NET [panNET] or midgut NET cohort).",
                "FlowRecruitmentDetails":"Subjects with well differentiated, metastatic or locally advanced, unresectable, pancreatic or midgut neuroendocrine tumours (NETs) and who had radiologically documented disease progression as per Response Evaluation Criteria in Solid Tumours (RECIST) v1.0 whilst receiving treatment with lanreotide Autogel® 120mg, every 28 days for at least 24 weeks were enrolled into this study in 25 centres across 10 countries.",
                "FlowGroupList":{
                  "FlowGroup":[
                    {
                      "FlowGroupId":"FG000",
                      "FlowGroupTitle":"Pancreatic NET (panNET) Cohort",
                      "FlowGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep subcutaneous (SC) injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (progressive disease [PD] or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                    },{
                      "FlowGroupId":"FG001",
                      "FlowGroupTitle":"Midgut NET Cohort",
                      "FlowGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                    }
                  ]
                },
                "FlowPeriodList":{
                  "FlowPeriod":[
                    {
                      "FlowPeriodTitle":"Overall Study",
                      "FlowMilestoneList":{
                        "FlowMilestone":[
                          {
                            "FlowMilestoneType":"STARTED",
                            "FlowAchievementList":{
                              "FlowAchievement":[
                                {
                                  "FlowAchievementGroupId":"FG000",
                                  "FlowAchievementNumSubjects":"48"
                                },{
                                  "FlowAchievementGroupId":"FG001",
                                  "FlowAchievementNumSubjects":"51"
                                }
                              ]
                            }
                          },{
                            "FlowMilestoneType":"COMPLETED",
                            "FlowAchievementList":{
                              "FlowAchievement":[
                                {
                                  "FlowAchievementGroupId":"FG000",
                                  "FlowAchievementNumSubjects":"43"
                                },{
                                  "FlowAchievementGroupId":"FG001",
                                  "FlowAchievementNumSubjects":"46"
                                }
                              ]
                            }
                          },{
                            "FlowMilestoneType":"NOT COMPLETED",
                            "FlowAchievementList":{
                              "FlowAchievement":[
                                {
                                  "FlowAchievementGroupId":"FG000",
                                  "FlowAchievementNumSubjects":"5"
                                },{
                                  "FlowAchievementGroupId":"FG001",
                                  "FlowAchievementNumSubjects":"5"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "FlowDropWithdrawList":{
                        "FlowDropWithdraw":[
                          {
                            "FlowDropWithdrawType":"Adverse Event",
                            "FlowReasonList":{
                              "FlowReason":[
                                {
                                  "FlowReasonGroupId":"FG000",
                                  "FlowReasonNumSubjects":"2"
                                },{
                                  "FlowReasonGroupId":"FG001",
                                  "FlowReasonNumSubjects":"2"
                                }
                              ]
                            }
                          },{
                            "FlowDropWithdrawType":"Consent Withdrawn",
                            "FlowReasonList":{
                              "FlowReason":[
                                {
                                  "FlowReasonGroupId":"FG000",
                                  "FlowReasonNumSubjects":"2"
                                },{
                                  "FlowReasonGroupId":"FG001",
                                  "FlowReasonNumSubjects":"0"
                                }
                              ]
                            }
                          },{
                            "FlowDropWithdrawType":"Local PD",
                            "FlowReasonList":{
                              "FlowReason":[
                                {
                                  "FlowReasonGroupId":"FG000",
                                  "FlowReasonNumSubjects":"0"
                                },{
                                  "FlowReasonGroupId":"FG001",
                                  "FlowReasonNumSubjects":"2"
                                }
                              ]
                            }
                          },{
                            "FlowDropWithdrawType":"Investigator Decision",
                            "FlowReasonList":{
                              "FlowReason":[
                                {
                                  "FlowReasonGroupId":"FG000",
                                  "FlowReasonNumSubjects":"1"
                                },{
                                  "FlowReasonGroupId":"FG001",
                                  "FlowReasonNumSubjects":"1"
                                }
                              ]
                            }
                          }
                        ]
                      }
                    }
                  ]
                }
              },
              "BaselineCharacteristicsModule":{
                "BaselinePopulationDescription":"The full analysis set (FAS) included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study.",
                "BaselineGroupList":{
                  "BaselineGroup":[
                    {
                      "BaselineGroupId":"BG000",
                      "BaselineGroupTitle":"PanNET Cohort",
                      "BaselineGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                    },{
                      "BaselineGroupId":"BG001",
                      "BaselineGroupTitle":"Midgut NET Cohort",
                      "BaselineGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                    },{
                      "BaselineGroupId":"BG002",
                      "BaselineGroupTitle":"Total",
                      "BaselineGroupDescription":"Total of all reporting groups"
                    }
                  ]
                },
                "BaselineDenomList":{
                  "BaselineDenom":[
                    {
                      "BaselineDenomUnits":"Participants",
                      "BaselineDenomCountList":{
                        "BaselineDenomCount":[
                          {
                            "BaselineDenomCountGroupId":"BG000",
                            "BaselineDenomCountValue":"48"
                          },{
                            "BaselineDenomCountGroupId":"BG001",
                            "BaselineDenomCountValue":"51"
                          },{
                            "BaselineDenomCountGroupId":"BG002",
                            "BaselineDenomCountValue":"99"
                          }
                        ]
                      }
                    }
                  ]
                },
                "BaselineMeasureList":{
                  "BaselineMeasure":[
                    {
                      "BaselineMeasureTitle":"Age, Continuous",
                      "BaselineMeasureParamType":"Mean",
                      "BaselineMeasureDispersionType":"Standard Deviation",
                      "BaselineMeasureUnitOfMeasure":"years",
                      "BaselineClassList":{
                        "BaselineClass":[
                          {
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"63.3",
                                        "BaselineMeasurementSpread":"10.6"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"67.1",
                                        "BaselineMeasurementSpread":"8.2"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"65.2",
                                        "BaselineMeasurementSpread":"9.6"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "BaselineMeasureTitle":"Sex: Female, Male",
                      "BaselineMeasureParamType":"Count of Participants",
                      "BaselineMeasureUnitOfMeasure":"Participants",
                      "BaselineClassList":{
                        "BaselineClass":[
                          {
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineCategoryTitle":"Female",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"28"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"22"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"50"
                                      }
                                    ]
                                  }
                                },{
                                  "BaselineCategoryTitle":"Male",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"20"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"29"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"49"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "BaselineMeasureTitle":"Race/Ethnicity, Customized",
                      "BaselineMeasurePopulationDescription":"French local regulation does not allow the collection of race and therefore French subjects are not included in this baseline measure.",
                      "BaselineMeasureParamType":"Count of Participants",
                      "BaselineMeasureUnitOfMeasure":"Participants",
                      "BaselineClassList":{
                        "BaselineClass":[
                          {
                            "BaselineClassTitle":"Race",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"36"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"38"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"74"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineCategoryTitle":"Asian",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"0"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"1"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"1"
                                      }
                                    ]
                                  }
                                },{
                                  "BaselineCategoryTitle":"White",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"35"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"37"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"72"
                                      }
                                    ]
                                  }
                                },{
                                  "BaselineCategoryTitle":"Other",
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"1"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"0"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"1"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "BaselineMeasureTitle":"Region of Enrollment",
                      "BaselineMeasureParamType":"Number",
                      "BaselineMeasureUnitOfMeasure":"participants",
                      "BaselineClassList":{
                        "BaselineClass":[
                          {
                            "BaselineClassTitle":"Netherlands",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"1"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"3"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"4"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Belgium",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"3"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"2"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"5"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Ireland",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"2"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"0"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"2"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Denmark",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"1"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"2"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"3"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Poland",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"12"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"10"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"22"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Italy",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"2"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"6"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"8"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"United Kingdom",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"6"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"9"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"15"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"France",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"12"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"13"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"25"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Germany",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"8"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"3"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"11"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Spain",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"1"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"3"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"4"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "BaselineMeasureTitle":"Quality of Life (QoL) Questionnaire Core 30 (QLQ-C30) Score",
                      "BaselineMeasureDescription":"QoL was measured Using European Organisation Into the Research and Treatment of Cancer (EORTC), QLQ-C30 v3.0. The global health status sub-score was assessed using the last 2 questions which represented subject's assessment of overall health & QoL. Each question was coded on a 7-point scale (1=very poor to 7=excellent). The sub-score was transformed to range from 0-100, with a high score for global health status representing a high QoL.",
                      "BaselineMeasurePopulationDescription":"Only subjects who had a QLQ-C30 measure at baseline are included.",
                      "BaselineMeasureParamType":"Mean",
                      "BaselineMeasureDispersionType":"Standard Deviation",
                      "BaselineMeasureUnitOfMeasure":"score on a scale",
                      "BaselineClassList":{
                        "BaselineClass":[
                          {
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"46"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"50"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"96"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"68.12",
                                        "BaselineMeasurementSpread":"19.74"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"67.83",
                                        "BaselineMeasurementSpread":"20.76"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"67.97",
                                        "BaselineMeasurementSpread":"20.17"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "BaselineMeasureTitle":"EuroQoL 5 Dimensions, 5 Levels (EQ-5D-5L) v1.0 Questionnaire Descriptive System Score",
                      "BaselineMeasureDescription":"The EQ-5D-5L descriptive system comprised the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension had 5 levels: no problems, slight problems, moderate problems, severe problems, extreme problems. The EQ-5D-5L health states, defined by the EQ-5D-5L descriptive system, was converted into a single index value with scores ranging from 0 (no problems) to 1 (extreme problems).",
                      "BaselineMeasurePopulationDescription":"Only subjects with a EQ-5D-5L index value at baseline are included.",
                      "BaselineMeasureParamType":"Mean",
                      "BaselineMeasureDispersionType":"Standard Deviation",
                      "BaselineMeasureUnitOfMeasure":"score on a scale",
                      "BaselineClassList":{
                        "BaselineClass":[
                          {
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"45"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"45"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"90"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"0.82",
                                        "BaselineMeasurementSpread":"0.17"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"0.83",
                                        "BaselineMeasurementSpread":"0.14"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"0.83",
                                        "BaselineMeasurementSpread":"0.15"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "BaselineMeasureTitle":"EQ-5D-5L Visual Analogue Scale (VAS) Score",
                      "BaselineMeasureDescription":"The EQ-5D-5L VAS recorded the subject's self-rated health on a vertical VAS which is numbered from 0 (worst health state) to 100 (best health state).",
                      "BaselineMeasurePopulationDescription":"Only subjects with a EQ-5D-5L VAS score at baseline are included.",
                      "BaselineMeasureParamType":"Mean",
                      "BaselineMeasureDispersionType":"Standard Deviation",
                      "BaselineMeasureUnitOfMeasure":"score on a scale",
                      "BaselineClassList":{
                        "BaselineClass":[
                          {
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"47"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"44"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"91"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"75.02",
                                        "BaselineMeasurementSpread":"17.93"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"70.45",
                                        "BaselineMeasurementSpread":"14.93"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"72.81",
                                        "BaselineMeasurementSpread":"16.62"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "BaselineMeasureTitle":"QoL Questionnaire Gastrointestinal Neuroendocrine Tumour 21 (QLQ-GI.NET21) Score",
                      "BaselineMeasureDescription":"The EORTC QLQ-GI.NET21 module comprised 21 questions that used a 4-point scale (1 = Not at all, 2 = A little, 3 = Quite a bit, 4 = Very much) to evaluate 3 defined multi-item symptom scales (endocrine, gastrointestinal and treatment related side effects), 2 single item symptoms (bone/muscle pain and concern about weight loss), 2 psychosocial scales (social function and disease-related worries) and 2 single items (sexuality and communication). Answers were converted on a grading scale and then individual sub-scores transformed to range from 0 to 100 with a higher score = more or worse problems.",
                      "BaselineMeasurePopulationDescription":"Only subjects who had a QLQ GI.NET21 measure at baseline are included.",
                      "BaselineMeasureParamType":"Mean",
                      "BaselineMeasureDispersionType":"Standard Deviation",
                      "BaselineMeasureUnitOfMeasure":"score on a scale",
                      "BaselineClassList":{
                        "BaselineClass":[
                          {
                            "BaselineClassTitle":"Endocrine Symptoms",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"45"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"49"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"94"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"16.54",
                                        "BaselineMeasurementSpread":"22.30"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"19.73",
                                        "BaselineMeasurementSpread":"22.82"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"18.20",
                                        "BaselineMeasurementSpread":"22.51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Gastrointestinal Symptoms",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"45"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"49"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"94"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"21.70",
                                        "BaselineMeasurementSpread":"20.01"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"22.04",
                                        "BaselineMeasurementSpread":"17.17"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"21.88",
                                        "BaselineMeasurementSpread":"18.48"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Treatment Related Symptoms",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"32"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"32"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"64"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"11.63",
                                        "BaselineMeasurementSpread":"13.11"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"11.46",
                                        "BaselineMeasurementSpread":"13.75"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"11.55",
                                        "BaselineMeasurementSpread":"13.33"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Social Function",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"45"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"49"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"94"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"32.84",
                                        "BaselineMeasurementSpread":"24.18"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"35.03",
                                        "BaselineMeasurementSpread":"24.33"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"33.98",
                                        "BaselineMeasurementSpread":"24.15"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Disease Related Worries",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"45"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"49"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"94"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"44.44",
                                        "BaselineMeasurementSpread":"29.96"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"44.22",
                                        "BaselineMeasurementSpread":"25.83"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"44.33",
                                        "BaselineMeasurementSpread":"27.74"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Muscle/Bone Pain",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"44"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"92"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"26.52",
                                        "BaselineMeasurementSpread":"30.99"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"25.69",
                                        "BaselineMeasurementSpread":"30.16"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"26.09",
                                        "BaselineMeasurementSpread":"30.39"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Sexual Function",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"31"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"28"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"59"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"22.58",
                                        "BaselineMeasurementSpread":"30.29"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"17.86",
                                        "BaselineMeasurementSpread":"27.94"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"20.34",
                                        "BaselineMeasurementSpread":"29.04"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Information/Communication Function",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"45"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"93"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"3.70",
                                        "BaselineMeasurementSpread":"12.76"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"4.17",
                                        "BaselineMeasurementSpread":"11.14"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"3.94",
                                        "BaselineMeasurementSpread":"11.89"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Body Image",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"44"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"45"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"89"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"10.61",
                                        "BaselineMeasurementSpread":"23.60"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"15.56",
                                        "BaselineMeasurementSpread":"28.95"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"13.11",
                                        "BaselineMeasurementSpread":"26.41"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "BaselineMeasureTitle":"Categories of Proliferation index Ki67",
                      "BaselineMeasureParamType":"Number",
                      "BaselineMeasureUnitOfMeasure":"participants",
                      "BaselineClassList":{
                        "BaselineClass":[
                          {
                            "BaselineClassTitle":"≥10%",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"7"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"4"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"11"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"<10%",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"41"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"46"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"87"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Missing",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"0"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"1"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"1"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "BaselineMeasureTitle":"Tumour grading (according to WHO 2010 classification)",
                      "BaselineMeasureDescription":"According to the 2010 WHO classification, Grade 1 NET is defined as <=2% Ki-67 labelling index; and Grade 2 NET is defined as 3-20% Ki-67 labelling index. Grade 2 is considered to have a worse outcome.",
                      "BaselineMeasureParamType":"Number",
                      "BaselineMeasureUnitOfMeasure":"participants",
                      "BaselineClassList":{
                        "BaselineClass":[
                          {
                            "BaselineClassTitle":"Grade 1",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"12"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"29"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"41"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"Grade 2",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"36"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"22"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"58"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "BaselineMeasureTitle":"Hepatic tumour load",
                      "BaselineMeasureParamType":"Number",
                      "BaselineMeasureUnitOfMeasure":"participants",
                      "BaselineClassList":{
                        "BaselineClass":[
                          {
                            "BaselineClassTitle":">25%",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"7"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"9"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"16"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "BaselineClassTitle":"≤25%",
                            "BaselineClassDenomList":{
                              "BaselineClassDenom":[
                                {
                                  "BaselineClassDenomUnits":"Participants",
                                  "BaselineClassDenomCountList":{
                                    "BaselineClassDenomCount":[
                                      {
                                        "BaselineClassDenomCountGroupId":"BG000",
                                        "BaselineClassDenomCountValue":"48"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG001",
                                        "BaselineClassDenomCountValue":"51"
                                      },{
                                        "BaselineClassDenomCountGroupId":"BG002",
                                        "BaselineClassDenomCountValue":"99"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "BaselineCategoryList":{
                              "BaselineCategory":[
                                {
                                  "BaselineMeasurementList":{
                                    "BaselineMeasurement":[
                                      {
                                        "BaselineMeasurementGroupId":"BG000",
                                        "BaselineMeasurementValue":"41"
                                      },{
                                        "BaselineMeasurementGroupId":"BG001",
                                        "BaselineMeasurementValue":"42"
                                      },{
                                        "BaselineMeasurementGroupId":"BG002",
                                        "BaselineMeasurementValue":"83"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    }
                  ]
                }
              },
              "OutcomeMeasuresModule":{
                "OutcomeMeasureList":{
                  "OutcomeMeasure":[
                    {
                      "OutcomeMeasureType":"Primary",
                      "OutcomeMeasureTitle":"Median Progression Free Survival (PFS)",
                      "OutcomeMeasureDescription":"PFS was defined as the time from first injection of lanreotide Autogel® 120 mg every 14 days to progression or death. Disease progression was assessed by tumour response evaluation according to RECIST v1.0, every 12 weeks, measured by independent central review using the same imaging technique (computed tomography [CT] scan or magnetic resonance imaging [MRI]) for each subject throughout the study. The median PFS time was estimated using the Kaplan Meier method for each cohort.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Median",
                      "OutcomeMeasureDispersionType":"95% Confidence Interval",
                      "OutcomeMeasureUnitOfMeasure":"months",
                      "OutcomeMeasureTimeFrame":"From Day 1 up to Week 60 for the panNET cohort and Week 103 for the midgut NET cohort",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Midgut NET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"48"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"51"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"5.6",
                                        "OutcomeMeasurementLowerLimit":"5.5",
                                        "OutcomeMeasurementUpperLimit":"8.3"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"8.3",
                                        "OutcomeMeasurementLowerLimit":"5.6",
                                        "OutcomeMeasurementUpperLimit":"11.1"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Median Time to Progression",
                      "OutcomeMeasureDescription":"Time to Progression was defined as time from first injection of lanreotide Autogel® 120 mg every 14 days to progression. Disease progression was assessed by tumour response evaluation according to RECIST v1.0, every 12 weeks, measured by independent central review using the same imaging technique (CT scan or MRI) for each subject throughout the study. Median time to progression was estimated using the Kaplan Meier method for each cohort.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Median",
                      "OutcomeMeasureDispersionType":"95% Confidence Interval",
                      "OutcomeMeasureUnitOfMeasure":"months",
                      "OutcomeMeasureTimeFrame":"From Day 1 up to Week 60 for the panNET cohort and Week 103 for the midgut NET cohort",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Midgut NET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"48"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"51"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"5.6",
                                        "OutcomeMeasurementLowerLimit":"5.5",
                                        "OutcomeMeasurementUpperLimit":"8.3"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"8.7",
                                        "OutcomeMeasurementLowerLimit":"8.3",
                                        "OutcomeMeasurementUpperLimit":"13.9"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Percentage of Subjects Alive and Progression Free",
                      "OutcomeMeasureDescription":"The percentage of subjects alive and progression-free was assessed throughout the study up to Week 60 for the panNET cohort and Week 96 for the midgut cohort. Disease progression was assessed by tumour response evaluation according to RECIST v1.0, every 12 weeks measured by independent central review using the same imaging technique (CT scan or MRI) for each subject throughout the study. The percentage of subjects alive and progression free was estimated using the Kaplan Meier method for each cohort.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Number",
                      "OutcomeMeasureDispersionType":"95% Confidence Interval",
                      "OutcomeMeasureUnitOfMeasure":"percentage of subjects",
                      "OutcomeMeasureTimeFrame":"Weeks 12, 24, 36, 48, 60 (for both cohorts) and Weeks 72, 84 and 96 (for midgut NET cohort)",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Midgut NET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"48"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"51"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"Week 12",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"93.3",
                                        "OutcomeMeasurementLowerLimit":"80.7",
                                        "OutcomeMeasurementUpperLimit":"97.8"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"91.8",
                                        "OutcomeMeasurementLowerLimit":"79.7",
                                        "OutcomeMeasurementUpperLimit":"96.9"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Week 24",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"64.4",
                                        "OutcomeMeasurementLowerLimit":"48.7",
                                        "OutcomeMeasurementUpperLimit":"76.5"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"65.3",
                                        "OutcomeMeasurementLowerLimit":"50.3",
                                        "OutcomeMeasurementUpperLimit":"76.8"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Week 36",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"37.8",
                                        "OutcomeMeasurementLowerLimit":"23.9",
                                        "OutcomeMeasurementUpperLimit":"51.6"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"59.2",
                                        "OutcomeMeasurementLowerLimit":"44.2",
                                        "OutcomeMeasurementUpperLimit":"71.4"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Week 48",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"28.5",
                                        "OutcomeMeasurementLowerLimit":"16.2",
                                        "OutcomeMeasurementUpperLimit":"42.1"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"38.3",
                                        "OutcomeMeasurementLowerLimit":"24.8",
                                        "OutcomeMeasurementUpperLimit":"51.6"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Week 60",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"20.7",
                                        "OutcomeMeasurementLowerLimit":"9.0",
                                        "OutcomeMeasurementUpperLimit":"35.7"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"36.1",
                                        "OutcomeMeasurementLowerLimit":"22.9",
                                        "OutcomeMeasurementUpperLimit":"49.5"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Week 72",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"0"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"29.8",
                                        "OutcomeMeasurementLowerLimit":"17.6",
                                        "OutcomeMeasurementUpperLimit":"42.9"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Week 84",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"0"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"27.5",
                                        "OutcomeMeasurementLowerLimit":"15.7",
                                        "OutcomeMeasurementUpperLimit":"40.5"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Week 96",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"0"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"25.2",
                                        "OutcomeMeasurementLowerLimit":"13.9",
                                        "OutcomeMeasurementUpperLimit":"38.1"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Overall Survival",
                      "OutcomeMeasureDescription":"Overall survival was defined as the time in months from the first injection of lanreotide Autogel® 120 mg every 14 days to death due to any cause. Median overall survival was estimated using the Kaplan Meier method for each cohort.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Median",
                      "OutcomeMeasureDispersionType":"95% Confidence Interval",
                      "OutcomeMeasureUnitOfMeasure":"months",
                      "OutcomeMeasureTimeFrame":"From Day 1 up to Week 60 for the panNET cohort and Week 103 for the midgut NET cohort",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability"
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Midgut NET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"48"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"51"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"NA",
                                        "OutcomeMeasurementLowerLimit":"NA",
                                        "OutcomeMeasurementUpperLimit":"NA",
                                        "OutcomeMeasurementComment":"The median overall survival from the Kaplan Meier model was not reached for this cohort."
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"NA",
                                        "OutcomeMeasurementLowerLimit":"NA",
                                        "OutcomeMeasurementUpperLimit":"NA",
                                        "OutcomeMeasurementComment":"The median overall survival from the Kaplan Meier model was not reached for this cohort."
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Objective Response Rate (ORR)",
                      "OutcomeMeasureDescription":"The ORR was defined as the percentage of subjects who achieve either complete response (CR) or partial response (PR) according to RECIST v1.0 criteria. ORR was evaluated every 12 weeks and results are presented for each cohort.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Number",
                      "OutcomeMeasureDispersionType":"95% Confidence Interval",
                      "OutcomeMeasureUnitOfMeasure":"percentage of subjects",
                      "OutcomeMeasureTimeFrame":"Weeks 12, 24, 36, 48, 60 (for both cohorts) and Weeks 72, 84, and 96 (for midgut cohort)",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Midgut NET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"48"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"51"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"Week 12",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"7.4"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"7.0"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Week 24",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"7.4"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"7.0"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Week 36",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"7.4"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"7.0"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Week 48",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"7.4"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"7.0"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Week 60",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"7.4"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"2.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"10.4"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Week 72",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"0"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"3.9",
                                        "OutcomeMeasurementLowerLimit":"0.5",
                                        "OutcomeMeasurementUpperLimit":"13.5"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Week 84",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"0"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"2.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"10.4"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Week 96",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"0"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"2.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"10.4"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Disease Control Rate (DCR)",
                      "OutcomeMeasureDescription":"The DCR was defined as the percentage of subjects who achieved CR plus PR plus Stable Disease (SD), evaluated according to RECIST v1.0 criteria. The DCR at Weeks 24 and 48 is presented for each cohort.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Number",
                      "OutcomeMeasureDispersionType":"95% Confidence Interval",
                      "OutcomeMeasureUnitOfMeasure":"percentage of subjects",
                      "OutcomeMeasureTimeFrame":"Weeks 24 and 48",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Midgut NET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"48"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"51"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"Week 24",
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"43.8",
                                        "OutcomeMeasurementLowerLimit":"29.5",
                                        "OutcomeMeasurementUpperLimit":"58.8"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"58.8",
                                        "OutcomeMeasurementLowerLimit":"44.2",
                                        "OutcomeMeasurementUpperLimit":"72.4"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Week 48",
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"22.9",
                                        "OutcomeMeasurementLowerLimit":"12.0",
                                        "OutcomeMeasurementUpperLimit":"37.3"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"33.3",
                                        "OutcomeMeasurementLowerLimit":"20.8",
                                        "OutcomeMeasurementUpperLimit":"47.9"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Best Overall Response Rate",
                      "OutcomeMeasureDescription":"Best overall response was defined as the best response recorded from the initiation of treatment until disease progression, according to RECIST v1.0 evaluation. The percentage of subjects in each response category and those who were non-evaluable (i.e. with no tumour assessment after the start of study treatment) throughout the study are presented for each cohort.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Number",
                      "OutcomeMeasureDispersionType":"95% Confidence Interval",
                      "OutcomeMeasureUnitOfMeasure":"percentage of subjects",
                      "OutcomeMeasureTimeFrame":"From Day 1 up to Week 60 for the panNET cohort and Week 103 for the midgut NET cohort",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Midgut NET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"48"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"51"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"CR",
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"7.4"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"7.0"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"PR",
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"7.4"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"3.9",
                                        "OutcomeMeasurementLowerLimit":"0.5",
                                        "OutcomeMeasurementUpperLimit":"13.5"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"SD",
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"66.7",
                                        "OutcomeMeasurementLowerLimit":"51.6",
                                        "OutcomeMeasurementUpperLimit":"79.6"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"68.6",
                                        "OutcomeMeasurementLowerLimit":"54.1",
                                        "OutcomeMeasurementUpperLimit":"80.9"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"PD",
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"31.3",
                                        "OutcomeMeasurementLowerLimit":"18.7",
                                        "OutcomeMeasurementUpperLimit":"46.3"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"23.5",
                                        "OutcomeMeasurementLowerLimit":"12.8",
                                        "OutcomeMeasurementUpperLimit":"37.5"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Not evaluable",
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"7.4"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"2.0",
                                        "OutcomeMeasurementLowerLimit":"0.0",
                                        "OutcomeMeasurementUpperLimit":"10.4"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Median Duration of Stable Disease",
                      "OutcomeMeasureDescription":"Median duration of SD was the time from first injection of lanreotide Autogel® 120 mg every 14 days until the first occurrence of PD by central assessment. Disease progression was assessed by tumour response evaluation according to RECIST v1.0, every 12 weeks, measured using the same imaging technique (CT scan or MRI) for each subject throughout the study. Median duration of stable disease was estimated using the Kaplan Meier method for each cohort.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Median",
                      "OutcomeMeasureDispersionType":"95% Confidence Interval",
                      "OutcomeMeasureUnitOfMeasure":"months",
                      "OutcomeMeasureTimeFrame":"From Day 1 up to Week 60 for the panNET cohort and Week 103 for the midgut NET cohort",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Midgut NET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"48"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"51"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"8.3",
                                        "OutcomeMeasurementLowerLimit":"8.0",
                                        "OutcomeMeasurementUpperLimit":"13.8"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"13.8",
                                        "OutcomeMeasurementLowerLimit":"8.6",
                                        "OutcomeMeasurementUpperLimit":"NA",
                                        "OutcomeMeasurementComment":"95% confidence interval upper limit could not be calculated as an insufficient number of events were observed."
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Factors Associated With PFS",
                      "OutcomeMeasureDescription":"A univariate cox proportional hazards model was used to assess whether the following factors were associated with PFS:\n\nHepatic tumour load: >25% versus reference ≤25%\nTumour Grade: Grade 2 versus reference Grade 1,\nPrevious surgery of the primary tumour: No versus reference Yes,\nProliferation index Ki67: ≥10% versus reference <10%\nDuration of treatment with lanreotide Autogel® 120 mg every 28 days by category: ≥median value versus reference <median value,\nAge by category: ≥65 years versus reference <65 years,\nTime from diagnosis to study entry by category: ≥3 years versus reference <3 years,\nTime interval between the two CT scans (pre-screening/screening): ≥12 months versus reference <12 months and\nSymptoms (diarrhoea or flushing at baseline): No versus reference Yes.\n\nEach factor was assessed for its importance in the Cox model for PFS in a univariate fashion.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Number",
                      "OutcomeMeasureDispersionType":"95% Confidence Interval",
                      "OutcomeMeasureUnitOfMeasure":"Hazard Ratio",
                      "OutcomeMeasureTimeFrame":"Screening/Baseline (Day 1)",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Midgut NET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"48"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"51"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"Hepatic tumour load: >25% Vs ≤25%",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.96",
                                        "OutcomeMeasurementLowerLimit":"0.40",
                                        "OutcomeMeasurementUpperLimit":"2.32"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.54",
                                        "OutcomeMeasurementLowerLimit":"0.70",
                                        "OutcomeMeasurementUpperLimit":"3.40"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Tumour Grade: 2 Vs 1",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.68",
                                        "OutcomeMeasurementLowerLimit":"0.32",
                                        "OutcomeMeasurementUpperLimit":"1.45"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.90",
                                        "OutcomeMeasurementLowerLimit":"0.46",
                                        "OutcomeMeasurementUpperLimit":"1.77"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Previous surgery: No Vs Yes",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"1.04",
                                        "OutcomeMeasurementLowerLimit":"0.53",
                                        "OutcomeMeasurementUpperLimit":"2.04"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"2.14",
                                        "OutcomeMeasurementLowerLimit":"0.83",
                                        "OutcomeMeasurementUpperLimit":"5.52"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Ki67: ≥10% Vs <10%",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"50"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"3.60",
                                        "OutcomeMeasurementLowerLimit":"1.39",
                                        "OutcomeMeasurementUpperLimit":"9.32"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"2.26",
                                        "OutcomeMeasurementLowerLimit":"0.67",
                                        "OutcomeMeasurementUpperLimit":"7.60"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Duration of treatment with lanreotide Autogel® 120 mg every 28 days: ≥median Vs <median",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.68",
                                        "OutcomeMeasurementLowerLimit":"0.34",
                                        "OutcomeMeasurementUpperLimit":"1.34"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.76",
                                        "OutcomeMeasurementLowerLimit":"0.40",
                                        "OutcomeMeasurementUpperLimit":"1.47"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Age: ≥65 years Vs <65 years",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"1.55",
                                        "OutcomeMeasurementLowerLimit":"0.79",
                                        "OutcomeMeasurementUpperLimit":"3.06"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.15",
                                        "OutcomeMeasurementLowerLimit":"0.58",
                                        "OutcomeMeasurementUpperLimit":"2.31"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Time from diagnosis: ≥3 years Vs <3 years",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.49",
                                        "OutcomeMeasurementLowerLimit":"0.25",
                                        "OutcomeMeasurementUpperLimit":"0.96"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.94",
                                        "OutcomeMeasurementLowerLimit":"0.49",
                                        "OutcomeMeasurementUpperLimit":"1.82"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Time between CT scans: ≥12 months Vs <12 months",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"51"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.47",
                                        "OutcomeMeasurementLowerLimit":"0.24",
                                        "OutcomeMeasurementUpperLimit":"0.94"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.72",
                                        "OutcomeMeasurementLowerLimit":"0.37",
                                        "OutcomeMeasurementUpperLimit":"1.39"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Symptoms: No Vs Yes",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"48"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"50"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"2.55",
                                        "OutcomeMeasurementLowerLimit":"0.89",
                                        "OutcomeMeasurementUpperLimit":"7.28"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.32",
                                        "OutcomeMeasurementLowerLimit":"0.68",
                                        "OutcomeMeasurementUpperLimit":"2.56"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Mean Change From Baseline in Number of Stools and Flushing Episodes",
                      "OutcomeMeasureDescription":"Symptom control was measured by the total number of stools (diarrhoea) and flushing episodes during the 7 days prior to the visit, reported orally by the subject to the investigator. The mean change from baseline in number of stools and flushing episodes reported at each visit is presented for each cohort.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study. Numbers analysed at each time point correspond to the number of subjects reporting episodes in the 7 days prior to the visit.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Mean",
                      "OutcomeMeasureDispersionType":"Standard Deviation",
                      "OutcomeMeasureUnitOfMeasure":"episodes",
                      "OutcomeMeasureTimeFrame":"Baseline (Day 1), Weeks 8,12, 48 and end of study (approximately 64 weeks for panNET cohort and 108 weeks for midgut NET cohort)",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Midgut NET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"48"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"51"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"Stools - Week 8",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"5"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"13"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"1.0",
                                        "OutcomeMeasurementSpread":"5.5"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-1.0",
                                        "OutcomeMeasurementSpread":"8.2"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Stools - Week 12",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"5"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"13"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"-1.2",
                                        "OutcomeMeasurementSpread":"7.9"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.7",
                                        "OutcomeMeasurementSpread":"2.5"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Stools - Week 48",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"2"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"5"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"-1.0",
                                        "OutcomeMeasurementSpread":"0.0"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"3.4",
                                        "OutcomeMeasurementSpread":"4.8"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Stools - End of Study",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"4"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"5"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.5",
                                        "OutcomeMeasurementSpread":"5.4"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-1.2",
                                        "OutcomeMeasurementSpread":"12.2"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Flushing - Week 8",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"3"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"9"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.7",
                                        "OutcomeMeasurementSpread":"2.1"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-3.3",
                                        "OutcomeMeasurementSpread":"8.3"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Flushing - Week 12",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"2"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"6"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"-1.0",
                                        "OutcomeMeasurementSpread":"0.0"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"1.5",
                                        "OutcomeMeasurementSpread":"10.0"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Flushing - Week 48",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"2"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"2"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"-1.0",
                                        "OutcomeMeasurementSpread":"0.0"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-1.5",
                                        "OutcomeMeasurementSpread":"2.1"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Flushing - End of Study",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"2"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"4"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.0",
                                        "OutcomeMeasurementSpread":"1.4"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-0.5",
                                        "OutcomeMeasurementSpread":"6.2"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Mean Change From Baseline in QoL Measured Using EORTC, QLQ-C30 v3.0 (Global Health Status Sub-score)",
                      "OutcomeMeasureDescription":"Subjects were instructed to complete the 30 questions in the EORTC-QLQ-C30 v3.0 questionnaire at baseline and every 12 weeks throughout the study.\n\nThe global health status sub-score was assessed using the last 2 questions which represented subject's assessment of overall health & QoL. Each question was coded on a 7-point scale (1=very poor to 7=excellent). The sub-score was transformed to range from 0-100, with a high score for global health status representing a high QoL. The mean change from baseline in the transformed global health status are presented for the end of study/early withdrawal visit, with a positive change indicating an improvement in QoL.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study. Only subjects with data available for analysis are presented.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Mean",
                      "OutcomeMeasureDispersionType":"Standard Deviation",
                      "OutcomeMeasureUnitOfMeasure":"score on a scale",
                      "OutcomeMeasureTimeFrame":"Baseline (Day 1) and end of study (approximately 64 weeks for panNET cohort and 108 weeks for midgut NET (and overall) cohort)",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Midgut NET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG002",
                            "OutcomeGroupTitle":"Overall",
                            "OutcomeGroupDescription":"All subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"22"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"25"
                                },{
                                  "OutcomeDenomCountGroupId":"OG002",
                                  "OutcomeDenomCountValue":"47"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"-0.38",
                                        "OutcomeMeasurementSpread":"15.32"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-1.33",
                                        "OutcomeMeasurementSpread":"17.13"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG002",
                                        "OutcomeMeasurementValue":"-0.89",
                                        "OutcomeMeasurementSpread":"16.14"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Mean Change From Baseline in EQ-5D-5L v1.0 Questionnaire (Descriptive System)",
                      "OutcomeMeasureDescription":"Subjects were instructed to complete the EQ-5D-5L descriptive system at baseline and every 12 weeks throughout the study.\n\nThe EQ-5D-5L descriptive system comprised the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension had 5 levels: no problems, slight problems, moderate problems, severe problems, extreme problems. The EQ-5D-5L health states, defined by the EQ-5D-5L descriptive system, was converted into a single index value with scores ranging from 0 (no problems) to 1 (extreme problems). The mean change from baseline at the end of study/early withdrawal visit is presented with a positive change from baseline in the index values indicating a worsening of symptoms.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study. Only subjects with data available for analysis are presented.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Mean",
                      "OutcomeMeasureDispersionType":"Standard Deviation",
                      "OutcomeMeasureUnitOfMeasure":"Index value",
                      "OutcomeMeasureTimeFrame":"Baseline (Day 1) and end of study (approximately 64 weeks for panNET cohort and 108 weeks for midgut NET (and overall) cohort)",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Midgut NET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG002",
                            "OutcomeGroupTitle":"Overall",
                            "OutcomeGroupDescription":"All subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"22"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"21"
                                },{
                                  "OutcomeDenomCountGroupId":"OG002",
                                  "OutcomeDenomCountValue":"43"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"-0.04",
                                        "OutcomeMeasurementSpread":"0.12"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.00",
                                        "OutcomeMeasurementSpread":"0.11"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG002",
                                        "OutcomeMeasurementValue":"-0.02",
                                        "OutcomeMeasurementSpread":"0.12"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Mean Change From Baseline in EQ-5D-5L v1.0 Questionnaire (VAS)",
                      "OutcomeMeasureDescription":"Subjects were instructed to complete the EQ-5D-5L VAS at baseline and every 12 weeks throughout the study. The EQ-5D-5L VAS recorded the subject's self-rated health on a vertical VAS which is numbered from 0 (worst health state) to 100 (best health state). The mean change from baseline at the end of study/early withdrawal visit is presented with a positive change in the VAS indicating an improvement in symptoms.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study. Only subjects with data available for analysis are presented.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Mean",
                      "OutcomeMeasureDispersionType":"Standard Deviation",
                      "OutcomeMeasureUnitOfMeasure":"score on a scale",
                      "OutcomeMeasureTimeFrame":"Baseline (Day 1) and end of study (approximately 64 weeks for panNET cohort and 108 weeks for midgut NET (and overall) cohort)",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Midgut NET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG002",
                            "OutcomeGroupTitle":"Overall",
                            "OutcomeGroupDescription":"All subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"21"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"21"
                                },{
                                  "OutcomeDenomCountGroupId":"OG002",
                                  "OutcomeDenomCountValue":"42"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"-1.90",
                                        "OutcomeMeasurementSpread":"14.80"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-1.76",
                                        "OutcomeMeasurementSpread":"9.34"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG002",
                                        "OutcomeMeasurementValue":"-1.83",
                                        "OutcomeMeasurementSpread":"12.22"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Mean Change From Baseline in QoL Questionnaire Gastrointestinal Neuroendocrine Tumour 21 (QLQ-GI.NET21; 2006)",
                      "OutcomeMeasureDescription":"Subjects were asked to complete the EORTC QLQ-GI.NET21 module which comprised 21 questions that used a 4-point scale (1 = Not at all, 2 = A little, 3 = Quite a bit, 4 = Very much) to evaluate 3 defined multi-item symptom scales (endocrine, gastrointestinal and treatment related side effects), 2 single item symptoms (bone/muscle pain and concern about weight loss), 2 psychosocial scales (social function and disease-related worries) and 2 other single items (sexuality and communication). Answers were converted into grading scale, with values between 0 and 100. Each individual sub-score was transformed to range from 0 to 100. The mean change from baseline at the end of study/early withdrawal visit is presented with a higher score representing more or worse problems.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study. Only subjects with data available for analysis are presented.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Mean",
                      "OutcomeMeasureDispersionType":"Standard Deviation",
                      "OutcomeMeasureUnitOfMeasure":"score on a scale",
                      "OutcomeMeasureTimeFrame":"Baseline (Day 1) and end of study (approximately 64 weeks for panNET cohort and 108 weeks for midgut NET (and overall) cohort)",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Midgut NET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG002",
                            "OutcomeGroupTitle":"Overall",
                            "OutcomeGroupDescription":"All subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"48"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"51"
                                },{
                                  "OutcomeDenomCountGroupId":"OG002",
                                  "OutcomeDenomCountValue":"99"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"Endocrine Symptoms",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"21"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"24"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG002",
                                        "OutcomeClassDenomCountValue":"45"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"-0.53",
                                        "OutcomeMeasurementSpread":"11.37"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-5.09",
                                        "OutcomeMeasurementSpread":"17.33"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG002",
                                        "OutcomeMeasurementValue":"-2.96",
                                        "OutcomeMeasurementSpread":"14.87"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Gastrointestinal Symptoms",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"21"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"24"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG002",
                                        "OutcomeClassDenomCountValue":"45"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"-3.49",
                                        "OutcomeMeasurementSpread":"14.24"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-2.78",
                                        "OutcomeMeasurementSpread":"15.96"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG002",
                                        "OutcomeMeasurementValue":"-3.11",
                                        "OutcomeMeasurementSpread":"15.02"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Treatment Related Symptoms",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"15"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"16"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG002",
                                        "OutcomeClassDenomCountValue":"31"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"5.93",
                                        "OutcomeMeasurementSpread":"15.64"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-3.47",
                                        "OutcomeMeasurementSpread":"14.47"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG002",
                                        "OutcomeMeasurementValue":"1.08",
                                        "OutcomeMeasurementSpread":"15.54"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Social Function",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"21"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"24"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG002",
                                        "OutcomeClassDenomCountValue":"45"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"-0.79",
                                        "OutcomeMeasurementSpread":"13.41"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-9.49",
                                        "OutcomeMeasurementSpread":"18.20"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG002",
                                        "OutcomeMeasurementValue":"-5.43",
                                        "OutcomeMeasurementSpread":"16.56"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Disease Related Worries",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"21"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"24"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG002",
                                        "OutcomeClassDenomCountValue":"45"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"3.17",
                                        "OutcomeMeasurementSpread":"15.47"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-0.93",
                                        "OutcomeMeasurementSpread":"27.40"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG002",
                                        "OutcomeMeasurementValue":"0.99",
                                        "OutcomeMeasurementSpread":"22.48"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Muscle/Bone Pain",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"20"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"24"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG002",
                                        "OutcomeClassDenomCountValue":"44"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"-1.67",
                                        "OutcomeMeasurementSpread":"33.29"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.00",
                                        "OutcomeMeasurementSpread":"36.78"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG002",
                                        "OutcomeMeasurementValue":"-0.76",
                                        "OutcomeMeasurementSpread":"34.84"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Sexual Function",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"14"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"12"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG002",
                                        "OutcomeClassDenomCountValue":"26"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"2.38",
                                        "OutcomeMeasurementSpread":"15.82"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-2.78",
                                        "OutcomeMeasurementSpread":"26.43"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG002",
                                        "OutcomeMeasurementValue":"0.00",
                                        "OutcomeMeasurementSpread":"21.08"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Information/Communication Function",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"21"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"23"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG002",
                                        "OutcomeClassDenomCountValue":"44"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"7.94",
                                        "OutcomeMeasurementSpread":"29.64"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-2.90",
                                        "OutcomeMeasurementSpread":"9.60"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG002",
                                        "OutcomeMeasurementValue":"2.27",
                                        "OutcomeMeasurementSpread":"22.04"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Body Image",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"20"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"22"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG002",
                                        "OutcomeClassDenomCountValue":"42"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.00",
                                        "OutcomeMeasurementSpread":"15.29"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-7.58",
                                        "OutcomeMeasurementSpread":"28.97"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG002",
                                        "OutcomeMeasurementValue":"-3.97",
                                        "OutcomeMeasurementSpread":"23.52"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Mean Change From Baseline in Nonspecific Tumour Biomarkers",
                      "OutcomeMeasureDescription":"Nonspecific tumour peptide biomarkers (chromogranin A [CgA], neuron specific enolase [NSE] and plasma/urinary 5-hydroxyindoleacetic acid [5-HIAA]) were evaluated in both pancreas and midgut subjects at baseline and Week 12 and every 12 weeks thereafter. At all scheduled visits, except baseline, plasma/urinary 5-HIAA was only performed in subjects with symptoms of carcinoid syndrome (diarrhoea and/or flushing) or if urinary 5-HIAA was elevated (above upper limit of normal [ULN]) at baseline. Mean change from baseline values were normalised by the ULN (xULN) and are presented for each cohort.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study. Only subjects with data available for analysis are presented.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Mean",
                      "OutcomeMeasureDispersionType":"Standard Deviation",
                      "OutcomeMeasureUnitOfMeasure":"xULN",
                      "OutcomeMeasureTimeFrame":"Baseline (Day 1) and end of study (approximately 64 weeks for panNET cohort and 108 weeks for midgut NET cohort)",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          },{
                            "OutcomeGroupId":"OG001",
                            "OutcomeGroupTitle":"Midgut NET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"48"
                                },{
                                  "OutcomeDenomCountGroupId":"OG001",
                                  "OutcomeDenomCountValue":"51"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"CgA",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"22"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"24"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.205",
                                        "OutcomeMeasurementSpread":"1.258"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"0.370",
                                        "OutcomeMeasurementSpread":"1.843"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"NSE",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"15"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"10"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"0.03",
                                        "OutcomeMeasurementSpread":"1.00"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"-0.49",
                                        "OutcomeMeasurementSpread":"1.86"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Plasma 5-HIAA",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"20"
                                      },{
                                        "OutcomeClassDenomCountGroupId":"OG001",
                                        "OutcomeClassDenomCountValue":"17"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"-0.42",
                                        "OutcomeMeasurementSpread":"1.44"
                                      },{
                                        "OutcomeMeasurementGroupId":"OG001",
                                        "OutcomeMeasurementValue":"3.90",
                                        "OutcomeMeasurementSpread":"7.39"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Mean Change From Baseline in PanNet Specific Tumour Biomarkers: Pancreatic Polypeptide, Gastrin",
                      "OutcomeMeasureDescription":"PanNET specific tumour peptide biomarkers were evaluated in pancreas subjects at baseline. Only the tumour biomarkers that were above normal range at baseline were evaluated every 12 weeks thereafter and at the end of study visit. The mean change from baseline values in picomole/liter (pmol/L) are presented for the end of study visit.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study. Only subjects in the panNET cohort with data available for analysis are presented.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Mean",
                      "OutcomeMeasureDispersionType":"Standard Deviation",
                      "OutcomeMeasureUnitOfMeasure":"pmol/L",
                      "OutcomeMeasureTimeFrame":"Baseline (Day 1) and end of study (approximately 64 weeks)",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"48"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeClassTitle":"Pancreatic Polypeptide",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"3"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"82.7",
                                        "OutcomeMeasurementSpread":"146.7"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          },{
                            "OutcomeClassTitle":"Gastrin",
                            "OutcomeClassDenomList":{
                              "OutcomeClassDenom":[
                                {
                                  "OutcomeClassDenomUnits":"Participants",
                                  "OutcomeClassDenomCountList":{
                                    "OutcomeClassDenomCount":[
                                      {
                                        "OutcomeClassDenomCountGroupId":"OG000",
                                        "OutcomeClassDenomCountValue":"4"
                                      }
                                    ]
                                  }
                                }
                              ]
                            },
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"-9.8",
                                        "OutcomeMeasurementSpread":"70.7"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    },{
                      "OutcomeMeasureType":"Secondary",
                      "OutcomeMeasureTitle":"Mean Change From Baseline in PanNet Specific Tumour Biomarkers: Glucagon",
                      "OutcomeMeasureDescription":"PanNET specific tumour peptide biomarkers were evaluated in pancreas subjects at baseline. Only the tumour biomarkers that were above normal range at baseline were evaluated every 12 weeks thereafter and at the end of study visit. The mean change from baseline values in nanograms (ng)/L are presented for the end of study visit.",
                      "OutcomeMeasurePopulationDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study. Only subjects in panNET cohort with data available for analysis are presented.",
                      "OutcomeMeasureReportingStatus":"Posted",
                      "OutcomeMeasureParamType":"Mean",
                      "OutcomeMeasureDispersionType":"Standard Deviation",
                      "OutcomeMeasureUnitOfMeasure":"ng/L",
                      "OutcomeMeasureTimeFrame":"Baseline (Day 1) and end of study (approximately 64 weeks)",
                      "OutcomeGroupList":{
                        "OutcomeGroup":[
                          {
                            "OutcomeGroupId":"OG000",
                            "OutcomeGroupTitle":"PanNET Cohort",
                            "OutcomeGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability."
                          }
                        ]
                      },
                      "OutcomeDenomList":{
                        "OutcomeDenom":[
                          {
                            "OutcomeDenomUnits":"Participants",
                            "OutcomeDenomCountList":{
                              "OutcomeDenomCount":[
                                {
                                  "OutcomeDenomCountGroupId":"OG000",
                                  "OutcomeDenomCountValue":"4"
                                }
                              ]
                            }
                          }
                        ]
                      },
                      "OutcomeClassList":{
                        "OutcomeClass":[
                          {
                            "OutcomeCategoryList":{
                              "OutcomeCategory":[
                                {
                                  "OutcomeMeasurementList":{
                                    "OutcomeMeasurement":[
                                      {
                                        "OutcomeMeasurementGroupId":"OG000",
                                        "OutcomeMeasurementValue":"5.5",
                                        "OutcomeMeasurementSpread":"36.4"
                                      }
                                    ]
                                  }
                                }
                              ]
                            }
                          }
                        ]
                      }
                    }
                  ]
                }
              },
              "AdverseEventsModule":{
                "EventsFrequencyThreshold":"0",
                "EventsTimeFrame":"Treatment emergent adverse events were recorded from the first dose of lanreotide Autogel® 120 mg on Day 1 until 28 days after the last treatment. Overall time frame of up to a maximum of 64 weeks for panNET cohort and 108 weeks for midgut NET (and overall) cohort.",
                "EventsDescription":"The FAS included all subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study.",
                "EventGroupList":{
                  "EventGroup":[
                    {
                      "EventGroupId":"EG000",
                      "EventGroupTitle":"PanNET Cohort",
                      "EventGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 48 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 48 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the panNET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability.",
                      "EventGroupDeathsNumAffected":"1",
                      "EventGroupDeathsNumAtRisk":"48",
                      "EventGroupSeriousNumAffected":"5",
                      "EventGroupSeriousNumAtRisk":"48",
                      "EventGroupOtherNumAffected":"41",
                      "EventGroupOtherNumAtRisk":"48"
                    },{
                      "EventGroupId":"EG001",
                      "EventGroupTitle":"Midgut NET Cohort",
                      "EventGroupDescription":"Subjects were treated with lanreotide Autogel® 120 mg, administered as deep SC injections, every 14 days starting from Day 1 (at a reduced dosing interval) for up to 96 weeks or until disease progression, death or unacceptable toxicity or tolerability. Subjects who had not progressed at Week 96 could continue study treatment with lanreotide Autogel® 120 mg every 14 days until 25 events (PD or death) in the midgut NET cohort had been observed. Additional visits were performed every 12 weeks until disease progression or death, or unacceptable toxicity or tolerability.",
                      "EventGroupDeathsNumAffected":"3",
                      "EventGroupDeathsNumAtRisk":"51",
                      "EventGroupSeriousNumAffected":"13",
                      "EventGroupSeriousNumAtRisk":"51",
                      "EventGroupOtherNumAffected":"47",
                      "EventGroupOtherNumAtRisk":"51"
                    },{
                      "EventGroupId":"EG002",
                      "EventGroupTitle":"Overall Subjects",
                      "EventGroupDescription":"All subjects who received at least one dose of lanreotide Autogel® 120 mg every 14 days during the study.",
                      "EventGroupDeathsNumAffected":"4",
                      "EventGroupDeathsNumAtRisk":"99",
                      "EventGroupSeriousNumAffected":"18",
                      "EventGroupSeriousNumAtRisk":"99",
                      "EventGroupOtherNumAffected":"88",
                      "EventGroupOtherNumAtRisk":"99"
                    }
                  ]
                },
                "SeriousEventList":{
                  "SeriousEvent":[
                    {
                      "SeriousEventTerm":"Cardiac failure",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Pulseless electrical activity",
                      "SeriousEventOrganSystem":"Cardiac disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Abdominal pain",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"2",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Diarrhoea",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Intestinal obstruction",
                      "SeriousEventOrganSystem":"Gastrointestinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Asthenia",
                      "SeriousEventOrganSystem":"General disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Chest pain",
                      "SeriousEventOrganSystem":"General disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"General physical health deterioration",
                      "SeriousEventOrganSystem":"General disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Anaphylactic reaction",
                      "SeriousEventOrganSystem":"Immune system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Peritonitis",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Viral infection",
                      "SeriousEventOrganSystem":"Infections and infestations",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Craniocerebral injury",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Fall",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Spinal fracture",
                      "SeriousEventOrganSystem":"Injury, poisoning and procedural complications",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Bone neoplasm",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Breast cancer",
                      "SeriousEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Spinal cord compression",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Syncope",
                      "SeriousEventOrganSystem":"Nervous system disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Pulmonary embolism",
                      "SeriousEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"3",
                            "SeriousEventStatsNumAffected":"2",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"4",
                            "SeriousEventStatsNumAffected":"3",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "SeriousEventTerm":"Hypotension",
                      "SeriousEventOrganSystem":"Vascular disorders",
                      "SeriousEventSourceVocabulary":"MedDRA 22.0",
                      "SeriousEventAssessmentType":"Systematic Assessment",
                      "SeriousEventStatsList":{
                        "SeriousEventStats":[
                          {
                            "SeriousEventStatsGroupId":"EG000",
                            "SeriousEventStatsNumEvents":"0",
                            "SeriousEventStatsNumAffected":"0",
                            "SeriousEventStatsNumAtRisk":"48"
                          },{
                            "SeriousEventStatsGroupId":"EG001",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"51"
                          },{
                            "SeriousEventStatsGroupId":"EG002",
                            "SeriousEventStatsNumEvents":"1",
                            "SeriousEventStatsNumAffected":"1",
                            "SeriousEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    }
                  ]
                },
                "OtherEventList":{
                  "OtherEvent":[
                    {
                      "OtherEventTerm":"Lymphopenia",
                      "OtherEventOrganSystem":"Blood and lymphatic system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Monocytopenia",
                      "OtherEventOrganSystem":"Blood and lymphatic system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Arrhythmia",
                      "OtherEventOrganSystem":"Cardiac disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Cardiac failure",
                      "OtherEventOrganSystem":"Cardiac disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Heart valve incompetence",
                      "OtherEventOrganSystem":"Cardiac disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Palpitations",
                      "OtherEventOrganSystem":"Cardiac disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Right ventricular failure",
                      "OtherEventOrganSystem":"Cardiac disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Tachycardia",
                      "OtherEventOrganSystem":"Cardiac disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Tricuspid valve disease",
                      "OtherEventOrganSystem":"Cardiac disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Deafness",
                      "OtherEventOrganSystem":"Ear and labyrinth disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Deafness unilateral",
                      "OtherEventOrganSystem":"Ear and labyrinth disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Ear pain",
                      "OtherEventOrganSystem":"Ear and labyrinth disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hypoacusis",
                      "OtherEventOrganSystem":"Ear and labyrinth disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Vertigo",
                      "OtherEventOrganSystem":"Ear and labyrinth disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Vertigo positional",
                      "OtherEventOrganSystem":"Ear and labyrinth disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Diplopia",
                      "OtherEventOrganSystem":"Eye disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Dry eye",
                      "OtherEventOrganSystem":"Eye disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Eye pain",
                      "OtherEventOrganSystem":"Eye disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Eye pruritus",
                      "OtherEventOrganSystem":"Eye disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Glaucoma",
                      "OtherEventOrganSystem":"Eye disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Ocular hyperaemia",
                      "OtherEventOrganSystem":"Eye disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Abdominal discomfort",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Abdominal distension",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"7",
                            "OtherEventStatsNumAffected":"6",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"7",
                            "OtherEventStatsNumAffected":"6",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Abdominal pain",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"13",
                            "OtherEventStatsNumAffected":"7",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"16",
                            "OtherEventStatsNumAffected":"12",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"29",
                            "OtherEventStatsNumAffected":"19",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Abdominal pain lower",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Abdominal pain upper",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"7",
                            "OtherEventStatsNumAffected":"6",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"9",
                            "OtherEventStatsNumAffected":"8",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Anal incontinence",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Anorectal discomfort",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Ascites",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Constipation",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"6",
                            "OtherEventStatsNumAffected":"4",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Diarrhoea",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"20",
                            "OtherEventStatsNumAffected":"14",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"35",
                            "OtherEventStatsNumAffected":"27",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"55",
                            "OtherEventStatsNumAffected":"41",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Dry mouth",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Dyspepsia",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Faeces discoloured",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Flatulence",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"8",
                            "OtherEventStatsNumAffected":"6",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"9",
                            "OtherEventStatsNumAffected":"7",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Gastrooesophageal reflux disease",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Gingival bleeding",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Gingival pain",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Glossodynia",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Haematochezia",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hernial eventration",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Inguinal hernia",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Nausea",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"5",
                            "OtherEventStatsNumAffected":"5",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"9",
                            "OtherEventStatsNumAffected":"6",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"14",
                            "OtherEventStatsNumAffected":"11",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Oral pain",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Pancreatic failure",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Proctalgia",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Steatorrhoea",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"5",
                            "OtherEventStatsNumAffected":"5",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Stomatitis",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Toothache",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Vomiting",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"9",
                            "OtherEventStatsNumAffected":"6",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"4",
                            "OtherEventStatsNumAffected":"4",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"13",
                            "OtherEventStatsNumAffected":"10",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Asthenia",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"24",
                            "OtherEventStatsNumAffected":"4",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"5",
                            "OtherEventStatsNumAffected":"4",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"29",
                            "OtherEventStatsNumAffected":"8",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Chest pain",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Fatigue",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"8",
                            "OtherEventStatsNumAffected":"7",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"11",
                            "OtherEventStatsNumAffected":"8",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"19",
                            "OtherEventStatsNumAffected":"15",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Gait disturbance",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hunger",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Influenza like illness",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"4",
                            "OtherEventStatsNumAffected":"4",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Injection site bruising",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Injection site pain",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Malaise",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Medical device site pain",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Oedema peripheral",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"4",
                            "OtherEventStatsNumAffected":"4",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Pain",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Peripheral swelling",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Polyp",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Pyrexia",
                      "OtherEventOrganSystem":"General disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"5",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"7",
                            "OtherEventStatsNumAffected":"4",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Bile duct stone",
                      "OtherEventOrganSystem":"Hepatobiliary disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Cholelithiasis",
                      "OtherEventOrganSystem":"Hepatobiliary disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hepatic failure",
                      "OtherEventOrganSystem":"Hepatobiliary disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Liver injury",
                      "OtherEventOrganSystem":"Hepatobiliary disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Drug hypersensitivity",
                      "OtherEventOrganSystem":"Immune system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Bronchitis",
                      "OtherEventOrganSystem":"Infections and infestations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Carbuncle",
                      "OtherEventOrganSystem":"Infections and infestations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Cystitis",
                      "OtherEventOrganSystem":"Infections and infestations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Cystitis bacterial",
                      "OtherEventOrganSystem":"Infections and infestations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Diverticulitis",
                      "OtherEventOrganSystem":"Infections and infestations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Folliculitis",
                      "OtherEventOrganSystem":"Infections and infestations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Herpes zoster",
                      "OtherEventOrganSystem":"Infections and infestations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Influenza",
                      "OtherEventOrganSystem":"Infections and infestations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"6",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"8",
                            "OtherEventStatsNumAffected":"5",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Lower respiratory tract infection",
                      "OtherEventOrganSystem":"Infections and infestations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"5",
                            "OtherEventStatsNumAffected":"4",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Nasopharyngitis",
                      "OtherEventOrganSystem":"Infections and infestations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"7",
                            "OtherEventStatsNumAffected":"7",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"6",
                            "OtherEventStatsNumAffected":"5",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"13",
                            "OtherEventStatsNumAffected":"12",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Respiratory tract infection",
                      "OtherEventOrganSystem":"Infections and infestations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Tonsillitis",
                      "OtherEventOrganSystem":"Infections and infestations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Upper respiratory tract infection",
                      "OtherEventOrganSystem":"Infections and infestations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Urinary tract infection",
                      "OtherEventOrganSystem":"Infections and infestations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"6",
                            "OtherEventStatsNumAffected":"4",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"7",
                            "OtherEventStatsNumAffected":"5",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Fall",
                      "OtherEventOrganSystem":"Injury, poisoning and procedural complications",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Incision site pain",
                      "OtherEventOrganSystem":"Injury, poisoning and procedural complications",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Incisional hernia",
                      "OtherEventOrganSystem":"Injury, poisoning and procedural complications",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Ligament sprain",
                      "OtherEventOrganSystem":"Injury, poisoning and procedural complications",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Muscle strain",
                      "OtherEventOrganSystem":"Injury, poisoning and procedural complications",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Post procedural complication",
                      "OtherEventOrganSystem":"Injury, poisoning and procedural complications",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Radiation skin injury",
                      "OtherEventOrganSystem":"Injury, poisoning and procedural complications",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Skin abrasion",
                      "OtherEventOrganSystem":"Injury, poisoning and procedural complications",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Alanine aminotransferase increased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Aspartate aminotransferase abnormal",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Aspartate aminotransferase increased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Bacterial test positive",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Blood alkaline phosphatase increased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"4",
                            "OtherEventStatsNumAffected":"4",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Blood bilirubin increased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Blood chromogranin A increased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Blood creatinine increased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Blood glucose decreased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Blood glucose increased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Blood potassium increased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Blood triglycerides increased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Blood urea increased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Blood urine present",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"C-reactive protein increased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Gamma-glutamyltransferase abnormal",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Gamma-glutamyltransferase decreased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Gamma-glutamyltransferase increased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Glycosylated haemoglobin increased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Lymphocyte count decreased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Neutrophil count decreased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Platelet count decreased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Specific gravity urine increased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Urine ketone body present",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Weight decreased",
                      "OtherEventOrganSystem":"Investigations",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Carbohydrate intolerance",
                      "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Decreased appetite",
                      "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"5",
                            "OtherEventStatsNumAffected":"5",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"7",
                            "OtherEventStatsNumAffected":"7",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hypercholesterolaemia",
                      "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hyperglycaemia",
                      "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hyperkalaemia",
                      "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hypernatraemia",
                      "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hypertriglyceridaemia",
                      "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hyperuricaemia",
                      "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hypoalbuminaemia",
                      "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hypocalcaemia",
                      "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hypoglycaemia",
                      "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"4",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hypokalaemia",
                      "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hyponatraemia",
                      "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Malnutrition",
                      "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Vitamin D deficiency",
                      "OtherEventOrganSystem":"Metabolism and nutrition disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Arthralgia",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"7",
                            "OtherEventStatsNumAffected":"5",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"7",
                            "OtherEventStatsNumAffected":"5",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Back pain",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"4",
                            "OtherEventStatsNumAffected":"4",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Exostosis",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Flank pain",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Intervertebral disc degeneration",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Intervertebral disc protrusion",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Joint swelling",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"5",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"5",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Mobility decreased",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Muscle spasms",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"4",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Musculoskeletal chest pain",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Musculoskeletal discomfort",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Musculoskeletal pain",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Myalgia",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Neck pain",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Osteoarthritis",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Osteoporosis",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Pain in extremity",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"4",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Periarthritis",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Rheumatoid arthritis",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Spinal pain",
                      "OtherEventOrganSystem":"Musculoskeletal and connective tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Metastases to liver",
                      "OtherEventOrganSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Ageusia",
                      "OtherEventOrganSystem":"Nervous system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Aphasia",
                      "OtherEventOrganSystem":"Nervous system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Balance disorder",
                      "OtherEventOrganSystem":"Nervous system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Dizziness",
                      "OtherEventOrganSystem":"Nervous system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"7",
                            "OtherEventStatsNumAffected":"5",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"10",
                            "OtherEventStatsNumAffected":"8",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Dizziness postural",
                      "OtherEventOrganSystem":"Nervous system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Head discomfort",
                      "OtherEventOrganSystem":"Nervous system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Headache",
                      "OtherEventOrganSystem":"Nervous system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"5",
                            "OtherEventStatsNumAffected":"4",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"8",
                            "OtherEventStatsNumAffected":"7",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Lethargy",
                      "OtherEventOrganSystem":"Nervous system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Poor quality sleep",
                      "OtherEventOrganSystem":"Nervous system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Presyncope",
                      "OtherEventOrganSystem":"Nervous system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Sciatica",
                      "OtherEventOrganSystem":"Nervous system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Syncope",
                      "OtherEventOrganSystem":"Nervous system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Taste disorder",
                      "OtherEventOrganSystem":"Nervous system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Tremor",
                      "OtherEventOrganSystem":"Nervous system disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Acrophobia",
                      "OtherEventOrganSystem":"Psychiatric disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Confusional state",
                      "OtherEventOrganSystem":"Psychiatric disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Insomnia",
                      "OtherEventOrganSystem":"Psychiatric disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Mood altered",
                      "OtherEventOrganSystem":"Psychiatric disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Panic attack",
                      "OtherEventOrganSystem":"Psychiatric disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Sleep disorder",
                      "OtherEventOrganSystem":"Psychiatric disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Chronic kidney disease",
                      "OtherEventOrganSystem":"Renal and urinary disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Dysuria",
                      "OtherEventOrganSystem":"Renal and urinary disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Haematuria",
                      "OtherEventOrganSystem":"Renal and urinary disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Urethral stenosis",
                      "OtherEventOrganSystem":"Renal and urinary disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Gynaecomastia",
                      "OtherEventOrganSystem":"Reproductive system and breast disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Asthma",
                      "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Cough",
                      "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"6",
                            "OtherEventStatsNumAffected":"6",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Dysphonia",
                      "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Dyspnoea",
                      "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"5",
                            "OtherEventStatsNumAffected":"4",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"5",
                            "OtherEventStatsNumAffected":"4",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Dyspnoea exertional",
                      "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"3",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Increased upper airway secretion",
                      "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Oropharyngeal pain",
                      "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Orthopnoea",
                      "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Productive cough",
                      "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Sputum discoloured",
                      "OtherEventOrganSystem":"Respiratory, thoracic and mediastinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Erythema",
                      "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hyperhidrosis",
                      "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Night sweats",
                      "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Photosensitivity reaction",
                      "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Pruritus",
                      "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"4",
                            "OtherEventStatsNumAffected":"3",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"5",
                            "OtherEventStatsNumAffected":"4",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Pruritus generalised",
                      "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Rash",
                      "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Skin fissures",
                      "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Skin irritation",
                      "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Urticaria",
                      "OtherEventOrganSystem":"Skin and subcutaneous tissue disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Injection",
                      "OtherEventOrganSystem":"Surgical and medical procedures",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Deep vein thrombosis",
                      "OtherEventOrganSystem":"Vascular disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Flushing",
                      "OtherEventOrganSystem":"Vascular disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"14",
                            "OtherEventStatsNumAffected":"9",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"16",
                            "OtherEventStatsNumAffected":"11",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Haematoma",
                      "OtherEventOrganSystem":"Vascular disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hot flush",
                      "OtherEventOrganSystem":"Vascular disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"14",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"14",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Hypertension",
                      "OtherEventOrganSystem":"Vascular disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"9",
                            "OtherEventStatsNumAffected":"9",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"11",
                            "OtherEventStatsNumAffected":"11",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Peripheral venous disease",
                      "OtherEventOrganSystem":"Vascular disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Venous thrombosis limb",
                      "OtherEventOrganSystem":"Vascular disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"0",
                            "OtherEventStatsNumAffected":"0",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    },{
                      "OtherEventTerm":"Haemorrhoids",
                      "OtherEventOrganSystem":"Gastrointestinal disorders",
                      "OtherEventSourceVocabulary":"MedDRA 22.0",
                      "OtherEventAssessmentType":"Systematic Assessment",
                      "OtherEventStatsList":{
                        "OtherEventStats":[
                          {
                            "OtherEventStatsGroupId":"EG000",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"48"
                          },{
                            "OtherEventStatsGroupId":"EG001",
                            "OtherEventStatsNumEvents":"1",
                            "OtherEventStatsNumAffected":"1",
                            "OtherEventStatsNumAtRisk":"51"
                          },{
                            "OtherEventStatsGroupId":"EG002",
                            "OtherEventStatsNumEvents":"2",
                            "OtherEventStatsNumAffected":"2",
                            "OtherEventStatsNumAtRisk":"99"
                          }
                        ]
                      }
                    }
                  ]
                }
              },
              "MoreInfoModule":{
                "CertainAgreement":{
                  "AgreementPISponsorEmployee":"No",
                  "AgreementRestrictiveAgreement":"No"
                },
                "PointOfContact":{
                  "PointOfContactTitle":"Ipsen Medical Director",
                  "PointOfContactOrganization":"Ipsen",
                  "PointOfContactEMail":"clinical.trials@ipsen.com",
                  "PointOfContactPhone":"see email"
                }
              }
            },
            "DocumentSection":{
              "LargeDocumentModule":{
                "LargeDocList":{
                  "LargeDoc":[
                    {
                      "LargeDocTypeAbbrev":"Prot",
                      "LargeDocHasProtocol":"Yes",
                      "LargeDocHasSAP":"No",
                      "LargeDocHasICF":"No",
                      "LargeDocLabel":"Study Protocol",
                      "LargeDocDate":"January 9, 2017",
                      "LargeDocUploadDate":"10/15/2020 06:37",
                      "LargeDocFilename":"Prot_001.pdf"
                    },{
                      "LargeDocTypeAbbrev":"SAP",
                      "LargeDocHasProtocol":"No",
                      "LargeDocHasSAP":"Yes",
                      "LargeDocHasICF":"No",
                      "LargeDocLabel":"Statistical Analysis Plan",
                      "LargeDocDate":"January 13, 2020",
                      "LargeDocUploadDate":"10/15/2020 06:10",
                      "LargeDocFilename":"SAP_000.pdf"
                    }
                  ]
                }
              }
            },
            "DerivedSection":{
              "MiscInfoModule":{
                "VersionHolder":"August 17, 2023",
                "RemovedCountryList":{
                  "RemovedCountry":[
                    "United States"
                  ]
                }
              },
              "ConditionBrowseModule":{
                "ConditionMeshList":{
                  "ConditionMesh":[
                    {
                      "ConditionMeshId":"D000009369",
                      "ConditionMeshTerm":"Neoplasms"
                    },{
                      "ConditionMeshId":"D000018358",
                      "ConditionMeshTerm":"Neuroendocrine Tumors"
                    },{
                      "ConditionMeshId":"D000010190",
                      "ConditionMeshTerm":"Pancreatic Neoplasms"
                    }
                  ]
                },
                "ConditionAncestorList":{
                  "ConditionAncestor":[
                    {
                      "ConditionAncestorId":"D000017599",
                      "ConditionAncestorTerm":"Neuroectodermal Tumors"
                    },{
                      "ConditionAncestorId":"D000009373",
                      "ConditionAncestorTerm":"Neoplasms, Germ Cell and Embryonal"
                    },{
                      "ConditionAncestorId":"D000009370",
                      "ConditionAncestorTerm":"Neoplasms by Histologic Type"
                    },{
                      "ConditionAncestorId":"D000009380",
                      "ConditionAncestorTerm":"Neoplasms, Nerve Tissue"
                    },{
                      "ConditionAncestorId":"D000004067",
                      "ConditionAncestorTerm":"Digestive System Neoplasms"
                    },{
                      "ConditionAncestorId":"D000009371",
                      "ConditionAncestorTerm":"Neoplasms by Site"
                    },{
                      "ConditionAncestorId":"D000004701",
                      "ConditionAncestorTerm":"Endocrine Gland Neoplasms"
                    },{
                      "ConditionAncestorId":"D000004066",
                      "ConditionAncestorTerm":"Digestive System Diseases"
                    },{
                      "ConditionAncestorId":"D000010182",
                      "ConditionAncestorTerm":"Pancreatic Diseases"
                    },{
                      "ConditionAncestorId":"D000004700",
                      "ConditionAncestorTerm":"Endocrine System Diseases"
                    }
                  ]
                },
                "ConditionBrowseLeafList":{
                  "ConditionBrowseLeaf":[
                    {
                      "ConditionBrowseLeafId":"M12800",
                      "ConditionBrowseLeafName":"Pancreatic Neoplasms",
                      "ConditionBrowseLeafAsFound":"Pancreatic Tumor",
                      "ConditionBrowseLeafRelevance":"high"
                    },{
                      "ConditionBrowseLeafId":"M20185",
                      "ConditionBrowseLeafName":"Neuroendocrine Tumors",
                      "ConditionBrowseLeafAsFound":"Neuroendocrine Tumors",
                      "ConditionBrowseLeafRelevance":"high"
                    },{
                      "ConditionBrowseLeafId":"M19535",
                      "ConditionBrowseLeafName":"Neuroectodermal Tumors",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M20078",
                      "ConditionBrowseLeafName":"Neuroectodermal Tumors, Primitive",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M12008",
                      "ConditionBrowseLeafName":"Neoplasms, Germ Cell and Embryonal",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M12005",
                      "ConditionBrowseLeafName":"Neoplasms by Histologic Type",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M12015",
                      "ConditionBrowseLeafName":"Neoplasms, Nerve Tissue",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M6946",
                      "ConditionBrowseLeafName":"Digestive System Neoplasms",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M8576",
                      "ConditionBrowseLeafName":"Gastrointestinal Neoplasms",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M7553",
                      "ConditionBrowseLeafName":"Endocrine Gland Neoplasms",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M6945",
                      "ConditionBrowseLeafName":"Digestive System Diseases",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M8573",
                      "ConditionBrowseLeafName":"Gastrointestinal Diseases",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M12792",
                      "ConditionBrowseLeafName":"Pancreatic Diseases",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"M7552",
                      "ConditionBrowseLeafName":"Endocrine System Diseases",
                      "ConditionBrowseLeafRelevance":"low"
                    },{
                      "ConditionBrowseLeafId":"T4091",
                      "ConditionBrowseLeafName":"Neuroendocrine Tumor",
                      "ConditionBrowseLeafAsFound":"Neuroendocrine Tumors",
                      "ConditionBrowseLeafRelevance":"high"
                    },{
                      "ConditionBrowseLeafId":"T4387",
                      "ConditionBrowseLeafName":"Pancreatic Cancer",
                      "ConditionBrowseLeafAsFound":"Pancreatic Tumor",
                      "ConditionBrowseLeafRelevance":"high"
                    },{
                      "ConditionBrowseLeafId":"T4092",
                      "ConditionBrowseLeafName":"Neuroepithelioma",
                      "ConditionBrowseLeafRelevance":"low"
                    }
                  ]
                },
                "ConditionBrowseBranchList":{
                  "ConditionBrowseBranch":[
                    {
                      "ConditionBrowseBranchAbbrev":"BC04",
                      "ConditionBrowseBranchName":"Neoplasms"
                    },{
                      "ConditionBrowseBranchAbbrev":"BC06",
                      "ConditionBrowseBranchName":"Digestive System Diseases"
                    },{
                      "ConditionBrowseBranchAbbrev":"BC19",
                      "ConditionBrowseBranchName":"Gland and Hormone Related Diseases"
                    },{
                      "ConditionBrowseBranchAbbrev":"All",
                      "ConditionBrowseBranchName":"All Conditions"
                    },{
                      "ConditionBrowseBranchAbbrev":"Rare",
                      "ConditionBrowseBranchName":"Rare Diseases"
                    }
                  ]
                }
              },
              "InterventionBrowseModule":{
                "InterventionMeshList":{
                  "InterventionMesh":[
                    {
                      "InterventionMeshId":"C000060347",
                      "InterventionMeshTerm":"Lanreotide"
                    }
                  ]
                },
                "InterventionAncestorList":{
                  "InterventionAncestor":[
                    {
                      "InterventionAncestorId":"D000000970",
                      "InterventionAncestorTerm":"Antineoplastic Agents"
                    }
                  ]
                },
                "InterventionBrowseLeafList":{
                  "InterventionBrowseLeaf":[
                    {
                      "InterventionBrowseLeafId":"M146010",
                      "InterventionBrowseLeafName":"Lanreotide",
                      "InterventionBrowseLeafAsFound":"Beam radiation",
                      "InterventionBrowseLeafRelevance":"high"
                    }
                  ]
                },
                "InterventionBrowseBranchList":{
                  "InterventionBrowseBranch":[
                    {
                      "InterventionBrowseBranchAbbrev":"ANeo",
                      "InterventionBrowseBranchName":"Antineoplastic Agents"
                    },{
                      "InterventionBrowseBranchAbbrev":"All",
                      "InterventionBrowseBranchName":"All Drugs and Chemicals"
                    }
                  ]
                }
              }
            }
          }
        }
      ]
    }
  }
  